ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||||||||
folic acid
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
|
multiple interactions | ISO | 1 | 229,652,329 | 229,694,442 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
affects activity | EXP | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
affects expression | EXP | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions | EXP | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions | ISO | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
multiple interactions | ISO | 13 | 95,672,083 | 95,953,687 | RGD:6480464 | CTD | |
| G | ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
multiple interactions | ISO | 3 | 183,637,722 | 183,735,727 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
affects transport | EXP | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
multiple interactions | EXP | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
multiple interactions | EXP | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
decreases expression | ISO | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions | ISO | 17 | 61,554,422 | 61,575,741 | RGD:6480464 | CTD | |
| G | ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression | ISO | 17 | 61,554,422 | 61,575,741 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
multiple interactions | EXP | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACSS1 | acyl-CoA synthetase short-chain family member 1 |
|
multiple interactions | ISO | 20 | 24,986,866 | 25,038,818 | RGD:6480464 | CTD | |
| G | ACTA2 | actin, alpha 2, smooth muscle, aorta |
|
affects expression | EXP | 10 | 90,694,831 | 90,751,147 | RGD:6480464 | CTD | |
| G | ACTC1 | actin, alpha, cardiac muscle 1 |
|
affects expression | EXP | 15 | 35,080,297 | 35,087,927 | RGD:6480464 | CTD | |
| G | ACTC1 | actin, alpha, cardiac muscle 1 |
|
multiple interactions | ISO | 15 | 35,080,297 | 35,087,927 | RGD:6480464 | CTD | |
| G | ADAM11 | ADAM metallopeptidase domain 11 |
|
multiple interactions | ISO | 17 | 42,836,568 | 42,859,214 | RGD:6480464 | CTD | |
| G | ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
|
multiple interactions | ISO | 5 | 178,537,852 | 178,772,431 | RGD:6480464 | CTD | |
| G | ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
multiple interactions | ISO | 3 | 64,501,330 | 64,673,365 | RGD:6480464 | CTD | |
| G | ADAMTSL2 | ADAMTS-like 2 |
|
multiple interactions | ISO | 9 | 136,397,286 | 136,440,641 | RGD:6480464 | CTD | |
| G | ADC | arginine decarboxylase |
|
multiple interactions | ISO | 1 | 33,546,714 | 33,585,995 | RGD:6480464 | CTD | |
| G | ADCY3 | adenylate cyclase 3 |
|
multiple interactions | ISO | 2 | 25,042,038 | 25,142,055 | RGD:6480464 | CTD | |
| G | ADCY7 | adenylate cyclase 7 |
|
multiple interactions | ISO | 16 | 50,321,823 | 50,352,043 | RGD:6480464 | CTD | |
| G | ADD3 | adducin 3 (gamma) |
|
multiple interactions | ISO | 10 | 111,765,726 | 111,895,323 | RGD:6480464 | CTD | |
| G | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions | ISO | 4 | 99,992,129 | 100,009,931 | RGD:6480464 | CTD | |
| G | ADHFE1 | alcohol dehydrogenase, iron containing, 1 |
|
multiple interactions | ISO | 8 | 67,344,718 | 67,381,044 | RGD:6480464 | CTD | |
| G | ADIPOR2 | adiponectin receptor 2 |
|
multiple interactions | ISO | 12 | 1,800,247 | 1,897,845 | RGD:6480464 | CTD | |
| G | ADNP2 | ADNP homeobox 2 |
|
multiple interactions | ISO | 18 | 77,866,915 | 77,898,229 | RGD:6480464 | CTD | |
| G | ADORA2B | adenosine A2b receptor |
|
multiple interactions | ISO | 17 | 15,848,231 | 15,879,210 | RGD:6480464 | CTD | |
| G | ADRA2A | adrenoceptor alpha 2A |
|
multiple interactions | ISO | 10 | 112,836,790 | 112,840,665 | RGD:6480464 | CTD | |
| G | ADRB3 | adrenoceptor beta 3 |
|
multiple interactions | ISO | 8 | 37,820,513 | 37,824,184 | RGD:6480464 | CTD | |
| G | ADSSL1 | adenylosuccinate synthase like 1 |
|
multiple interactions | ISO | 14 | 105,190,534 | 105,213,647 | RGD:6480464 | CTD | |
| G | AEN | apoptosis enhancing nuclease |
|
multiple interactions | ISO | 15 | 89,164,527 | 89,175,512 | RGD:6480464 | CTD | |
| G | AFAP1 | actin filament associated protein 1 |
|
affects expression | EXP | 4 | 7,760,440 | 7,941,653 | RGD:6480464 | CTD | |
| G | AGO1 | argonaute RISC catalytic component 1 |
|
multiple interactions | ISO | 1 | 36,348,810 | 36,389,899 | RGD:6480464 | CTD | |
| G | AGR2 | anterior gradient 2 homolog (Xenopus laevis) |
|
increases expression | EXP | 7 | 16,832,264 | 16,844,738 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases localization | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AGTR1 | angiotensin II receptor, type 1 |
|
multiple interactions | ISO | 3 | 148,415,658 | 148,460,790 | RGD:6480464 | CTD | |
| G | AGTR1 | angiotensin II receptor, type 1 |
|
multiple interactions | ISO | 3 | 148,415,658 | 148,460,790 | RGD:6480464 | CTD | |
| G | AGTR2 | angiotensin II receptor, type 2 |
|
increases expression | ISO | X | 115,301,958 | 115,306,225 | RGD:6480464 | CTD | |
| G | AIG1 | androgen-induced 1 |
|
multiple interactions | ISO | 6 | 143,382,023 | 143,661,441 | RGD:6480464 | CTD | |
| G | AK4 | adenylate kinase 4 |
|
affects expression | EXP | 1 | 65,613,232 | 65,697,828 | RGD:6480464 | CTD | |
| G | AK7 | adenylate kinase 7 |
|
multiple interactions | ISO | 14 | 96,858,448 | 96,955,764 | RGD:6480464 | CTD | |
| G | AKAP12 | A kinase (PRKA) anchor protein 12 |
|
decreases expression | EXP | 6 | 151,561,134 | 151,679,694 | RGD:6480464 | CTD | |
| G | AKAP5 | A kinase (PRKA) anchor protein 5 |
|
multiple interactions | ISO | 14 | 64,932,217 | 64,941,221 | RGD:6480464 | CTD | |
| G | AKNA | AT-hook transcription factor |
|
multiple interactions | ISO | 9 | 117,096,429 | 117,156,685 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects binding | EXP | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects expression | ISO | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
affects expression | EXP | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
increases degradation | EXP | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
multiple interactions | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
affects activity | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions | ISO | 12 | 112,204,691 | 112,247,789 | RGD:6480464 | CTD | |
| G | AMD1 | adenosylmethionine decarboxylase 1 |
|
increases activity | ISO | 6 | 111,195,987 | 111,216,913 | RGD:6480464 | CTD | |
| G | AMD1 | adenosylmethionine decarboxylase 1 |
|
multiple interactions | ISO | 6 | 111,195,987 | 111,216,913 | RGD:6480464 | CTD | |
| G | ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) |
|
increases expression | EXP | 10 | 92,671,857 | 92,681,032 | RGD:6480464 | CTD | |
| G | ANTXR2 | anthrax toxin receptor 2 |
|
multiple interactions | ISO | 4 | 80,822,771 | 80,994,477 | RGD:6480464 | CTD | |
| G | ANXA13 | annexin A13 |
|
affects expression | EXP | 8 | 124,693,034 | 124,749,647 | RGD:6480464 | CTD | |
| G | AP1S3 | adaptor-related protein complex 1, sigma 3 subunit |
|
multiple interactions | ISO | 2 | 224,620,047 | 224,702,319 | RGD:6480464 | CTD | |
| G | APOA1 | apolipoprotein A-I |
|
multiple interactions | ISO | 11 | 116,706,469 | 116,708,338 | RGD:6480464 | CTD | |
| G | APOA2 | apolipoprotein A-II |
|
multiple interactions | ISO | 1 | 161,192,083 | 161,193,418 | RGD:6480464 | CTD | |
| G | APOA4 | apolipoprotein A-IV |
|
multiple interactions | ISO | 11 | 116,691,418 | 116,694,011 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B (including Ag(x) antigen) |
|
multiple interactions | EXP | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B (including Ag(x) antigen) |
|
increases expression | EXP | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B (including Ag(x) antigen) |
|
multiple interactions | ISO | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOE | apolipoprotein E |
|
affects response to substance | ISO | 19 | 45,409,039 | 45,412,650 | RGD:6480464 | CTD | |
| G | APOE | apolipoprotein E |
|
multiple interactions | ISO | 19 | 45,409,039 | 45,412,650 | RGD:6480464 | CTD | |
| G | ARHGAP29 | Rho GTPase activating protein 29 |
|
affects expression | EXP | 1 | 94,634,463 | 94,703,307 | RGD:6480464 | CTD | |
| G | ARL4C | ADP-ribosylation factor-like 4C |
|
affects expression | EXP | 2 | 235,401,685 | 235,405,693 | RGD:6480464 | CTD | |
| G | AS3MT | arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions | EXP | 10 | 104,629,210 | 104,661,656 | RGD:6480464 | CTD | |
| G | ASIP | agouti signaling protein |
|
increases methylation | ISO | 20 | 32,848,171 | 32,857,148 | RGD:6480464 | CTD | |
| G | ATF6B | activating transcription factor 6 beta |
|
affects expression | EXP | 6 | 32,083,045 | 32,096,017 | RGD:6480464 | CTD | |
| G | ATM | ataxia telangiectasia mutated |
|
affects expression | EXP | 11 | 108,093,559 | 108,239,826 | RGD:6480464 | CTD | |
| G | AXIN1 | axin 1 |
|
multiple interactions | ISO | 16 | 337,440 | 402,676 | RGD:6480464 | CTD | |
| G | B2M | beta-2-microglobulin |
|
affects expression | EXP | 15 | 45,003,685 | 45,010,357 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
affects expression | EXP | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BCHE | butyrylcholinesterase |
|
multiple interactions | ISO | 3 | 165,490,692 | 165,555,253 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
affects expression | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
affects expression | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
decreases expression | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
multiple interactions | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
|
affects expression | EXP | 2 | 111,878,491 | 111,926,022 | RGD:6480464 | CTD | |
| G | BFAR | bifunctional apoptosis regulator |
|
affects expression | EXP | 16 | 14,726,668 | 14,763,093 | RGD:6480464 | CTD | |
| G | BIRC2 | baculoviral IAP repeat containing 2 |
|
increases expression | EXP | 11 | 102,217,913 | 102,249,401 | RGD:6480464 | CTD | |
| G | BIRC2 | baculoviral IAP repeat containing 2 |
|
multiple interactions | ISO | 11 | 102,217,913 | 102,249,401 | RGD:6480464 | CTD | |
| G | BIRC3 | baculoviral IAP repeat containing 3 |
|
affects expression | EXP | 11 | 102,188,181 | 102,210,134 | RGD:6480464 | CTD | |
| G | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
affects expression | EXP | 10 | 133,781,204 | 133,795,435 | RGD:6480464 | CTD | |
| G | BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
affects expression | EXP | 8 | 26,240,523 | 26,270,644 | RGD:6480464 | CTD | |
| G | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 |
|
affects expression | ISO | 1 | 220,230,824 | 220,263,191 | RGD:6480464 | CTD | |
| G | CA2 | carbonic anhydrase II |
|
multiple interactions | ISO | 8 | 86,376,131 | 86,393,721 | RGD:6480464 | CTD | |
| G | CASC5 | cancer susceptibility candidate 5 |
|
multiple interactions | ISO | 15 | 40,886,447 | 40,954,881 | RGD:6480464 | CTD | |
| G | CASP12 | caspase 12 (gene/pseudogene) |
|
multiple interactions | ISO | 11 | 104,756,445 | 104,769,397 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
affects expression | EXP | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP6 | caspase 6, apoptosis-related cysteine peptidase |
|
affects expression | EXP | 4 | 110,609,785 | 110,624,629 | RGD:6480464 | CTD | |
| G | CASP7 | caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 10 | 115,438,921 | 115,490,668 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
affects expression | EXP | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASZ1 | castor zinc finger 1 |
|
multiple interactions | ISO | 1 | 10,696,661 | 10,856,733 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CBFA2T2 | core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
|
multiple interactions | ISO | 20 | 32,077,928 | 32,237,837 | RGD:6480464 | CTD | |
| G | CBLN2 | cerebellin 2 precursor |
|
multiple interactions | ISO | 18 | 70,203,915 | 70,211,723 | RGD:6480464 | CTD | |
| G | CBR3 | carbonyl reductase 3 |
|
multiple interactions | ISO | 21 | 37,507,263 | 37,518,860 | RGD:6480464 | CTD | |
| G | CBX1 | chromobox homolog 1 |
|
multiple interactions | ISO | 17 | 46,147,414 | 46,178,883 | RGD:6480464 | CTD | |
| G | CBX6 | chromobox homolog 6 |
|
multiple interactions | ISO | 22 | 39,260,243 | 39,268,258 | RGD:6480464 | CTD | |
| G | CC2D1B | coiled-coil and C2 domain containing 1B |
|
multiple interactions | ISO | 1 | 52,816,265 | 52,831,877 | RGD:6480464 | CTD | |
| G | CCDC103 | coiled-coil domain containing 103 |
|
multiple interactions | ISO | 17 | 42,977,080 | 42,981,047 | RGD:6480464 | CTD | |
| G | CCDC106 | coiled-coil domain containing 106 |
|
multiple interactions | ISO | 19 | 56,158,954 | 56,164,527 | RGD:6480464 | CTD | |
| G | CCDC109B | coiled-coil domain containing 109B |
|
multiple interactions | ISO | 4 | 110,481,355 | 110,608,872 | RGD:6480464 | CTD | |
| G | CCDC117 | coiled-coil domain containing 117 |
|
multiple interactions | ISO | 22 | 29,168,662 | 29,185,283 | RGD:6480464 | CTD | |
| G | CCDC3 | coiled-coil domain containing 3 |
|
multiple interactions | ISO | 10 | 12,938,625 | 13,043,704 | RGD:6480464 | CTD | |
| G | CCDC68 | coiled-coil domain containing 68 |
|
multiple interactions | ISO | 18 | 52,568,740 | 52,626,739 | RGD:6480464 | CTD | |
| G | CCDC80 | coiled-coil domain containing 80 |
|
multiple interactions | ISO | 3 | 112,323,407 | 112,359,977 | RGD:6480464 | CTD | |
| G | CCDC85A | coiled-coil domain containing 85A |
|
multiple interactions | ISO | 2 | 56,411,258 | 56,613,309 | RGD:6480464 | CTD | |
| G | CCDC88B | coiled-coil domain containing 88B |
|
multiple interactions | ISO | 11 | 64,107,690 | 64,125,006 | RGD:6480464 | CTD | |
| G | CCDC88C | coiled-coil domain containing 88C |
|
multiple interactions | ISO | 14 | 91,737,667 | 91,884,188 | RGD:6480464 | CTD | |
| G | CCDC9 | coiled-coil domain containing 9 |
|
multiple interactions | ISO | 19 | 47,759,731 | 47,775,210 | RGD:6480464 | CTD | |
| G | CCDC92 | coiled-coil domain containing 92 |
|
multiple interactions | ISO | 12 | 124,420,955 | 124,457,163 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
decreases expression | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
affects expression | EXP | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
decreases expression | EXP | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCNE1 | cyclin E1 |
|
affects expression | EXP | 19 | 30,302,901 | 30,315,215 | RGD:6480464 | CTD | |
| G | CCRL1 | chemokine (C-C motif) receptor-like 1 |
|
affects expression | EXP | 3 | 132,316,094 | 132,321,382 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
decreases expression | EXP | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH13 | cadherin 13, H-cadherin (heart) |
|
decreases expression | EXP | 16 | 82,660,399 | 83,830,215 | RGD:6480464 | CTD | |
| G | CDH3 | cadherin 3, type 1, P-cadherin (placental) |
|
increases expression | EXP | 16 | 68,678,151 | 68,732,957 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
affects expression | EXP | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
affects expression | EXP | 12 | 12,870,302 | 12,875,305 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
affects methylation | EXP | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
multiple interactions | EXP | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
affects methylation | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
affects expression | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CEP112 | centrosomal protein 112kDa |
|
multiple interactions | ISO | 17 | 63,631,658 | 64,188,212 | RGD:6480464 | CTD | |
| G | CFL1 | cofilin 1 (non-muscle) |
|
affects expression | ISO | 11 | 65,622,282 | 65,625,804 | RGD:6480464 | CTD | |
| G | CHEK1 | checkpoint kinase 1 |
|
affects expression | EXP | 11 | 125,495,031 | 125,546,150 | RGD:6480464 | CTD | |
| G | CHTF18 | CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 16 | 838,622 | 848,074 | RGD:6480464 | CTD | |
| G | CHURC1 | churchill domain containing 1 |
|
multiple interactions | ISO | 14 | 65,381,079 | 65,402,086 | RGD:6480464 | CTD | |
| G | CIAPIN1 | cytokine induced apoptosis inhibitor 1 |
|
multiple interactions | ISO | 16 | 57,462,086 | 57,481,369 | RGD:6480464 | CTD | |
| G | CIDEB | cell death-inducing DFFA-like effector b |
|
affects expression | EXP | 14 | 24,774,393 | 24,780,576 | RGD:6480464 | CTD | |
| G | CILP2 | cartilage intermediate layer protein 2 |
|
multiple interactions | ISO | 19 | 19,649,074 | 19,657,468 | RGD:6480464 | CTD | |
| G | CISD3 | CDGSH iron sulfur domain 3 |
|
multiple interactions | ISO | 17 | 36,886,510 | 36,891,858 | RGD:6480464 | CTD | |
| G | CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
|
multiple interactions | ISO | X | 71,521,488 | 71,527,037 | RGD:6480464 | CTD | |
| G | CITED4 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
multiple interactions | ISO | 1 | 41,326,728 | 41,328,018 | RGD:6480464 | CTD | |
| G | CLCA2 | chloride channel accessory 2 |
|
multiple interactions | ISO | 1 | 86,889,769 | 86,922,241 | RGD:6480464 | CTD | |
| G | CLGN | calmegin |
|
increases expression | EXP | 4 | 141,309,607 | 141,348,815 | RGD:6480464 | CTD | |
| G | CLU | clusterin |
|
increases expression | ISO | 8 | 27,454,434 | 27,472,328 | RGD:6480464 | CTD | |
| G | CLU | clusterin |
|
increases expression | ISO | 8 | 27,454,434 | 27,472,328 | RGD:6480464 | CTD | |
| G | CNTF | ciliary neurotrophic factor |
|
multiple interactions | EXP | 11 | 58,390,146 | 58,393,206 | RGD:6480464 | CTD | |
| G | COL1A2 | collagen, type I, alpha 2 |
|
multiple interactions | ISO | 7 | 94,023,873 | 94,060,544 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
multiple interactions | ISO | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
increases activity | ISO | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CRP | C-reactive protein, pentraxin-related |
|
multiple interactions | EXP | 1 | 159,682,079 | 159,684,379 | RGD:6480464 | CTD | |
| G | CRP | C-reactive protein, pentraxin-related |
|
multiple interactions | EXP | 1 | 159,682,079 | 159,684,379 | RGD:6480464 | CTD | |
| G | CRP | C-reactive protein, pentraxin-related |
|
decreases expression | EXP | 1 | 159,682,079 | 159,684,379 | RGD:6480464 | CTD | |
| G | CRY2 | cryptochrome 2 (photolyase-like) |
|
multiple interactions | ISO | 11 | 45,868,669 | 45,904,799 | RGD:6480464 | CTD | |
| G | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa |
|
affects expression | EXP | 3 | 41,240,942 | 41,281,939 | RGD:6480464 | CTD | |
| G | CTSC | cathepsin C |
|
affects expression | EXP | 11 | 88,026,760 | 88,070,941 | RGD:6480464 | CTD | |
| G | CXCR7 | chemokine (C-X-C motif) receptor 7 |
|
affects expression | EXP | 2 | 237,478,380 | 237,490,997 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
multiple interactions | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | DEK | DEK oncogene |
|
affects expression | EXP | 6 | 18,224,400 | 18,264,799 | RGD:6480464 | CTD | |
| G | DET1 | de-etiolated homolog 1 (Arabidopsis) |
|
multiple interactions | ISO | 15 | 89,055,714 | 89,089,912 | RGD:6480464 | CTD | |
| G | DHCR7 | 7-dehydrocholesterol reductase |
|
multiple interactions | ISO | 11 | 71,145,457 | 71,159,477 | RGD:6480464 | CTD | |
| G | DHFR | dihydrofolate reductase |
|
multiple interactions | EXP | 5 | 79,922,045 | 79,950,800 | RGD:6480464 | CTD | |
| G | DHFR | dihydrofolate reductase |
|
decreases abundance | EXP | 5 | 79,922,045 | 79,950,800 | RGD:6480464 | CTD | |
| G | DHFR | dihydrofolate reductase |
|
affects expression | EXP | 5 | 79,922,045 | 79,950,800 | RGD:6480464 | CTD | |
| G | DHFR | dihydrofolate reductase |
|
multiple interactions | ISO | 5 | 79,922,045 | 79,950,800 | RGD:6480464 | CTD | |
| G | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 |
|
multiple interactions | ISO | 10 | 12,110,934 | 12,165,224 | RGD:6480464 | CTD | |
| G | DHX29 | DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
|
multiple interactions | ISO | 5 | 54,552,073 | 54,603,521 | RGD:6480464 | CTD | |
| G | DHX33 | DEAH (Asp-Glu-Ala-His) box polypeptide 33 |
|
multiple interactions | ISO | 17 | 5,344,232 | 5,372,380 | RGD:6480464 | CTD | |
| G | DIABLO | diablo, IAP-binding mitochondrial protein |
|
increases expression | ISO | 12 | 122,692,209 | 122,712,068 | RGD:6480464 | CTD | |
| G | DIABLO | diablo, IAP-binding mitochondrial protein |
|
increases expression | ISO | 12 | 122,692,209 | 122,712,068 | RGD:6480464 | CTD | |
| G | DICER1 | dicer 1, ribonuclease type III |
|
multiple interactions | ISO | 14 | 95,552,565 | 95,623,759 | RGD:6480464 | CTD | |
| G | DIDO1 | death inducer-obliterator 1 |
|
multiple interactions | ISO | 20 | 61,509,090 | 61,569,304 | RGD:6480464 | CTD | |
| G | DIO3 | deiodinase, iodothyronine, type III |
|
multiple interactions | ISO | 14 | 102,027,688 | 102,029,789 | RGD:6480464 | CTD | |
| G | DKC1 | dyskeratosis congenita 1, dyskerin |
|
multiple interactions | ISO | X | 153,991,031 | 154,005,964 | RGD:6480464 | CTD | |
| G | DKK1 | dickkopf 1 homolog (Xenopus laevis) |
|
increases expression | EXP | 10 | 54,074,041 | 54,077,417 | RGD:6480464 | CTD | |
| G | DKK1 | dickkopf 1 homolog (Xenopus laevis) |
|
affects expression | EXP | 10 | 54,074,041 | 54,077,417 | RGD:6480464 | CTD | |
| G | DLX1 | distal-less homeobox 1 |
|
multiple interactions | ISO | 2 | 172,950,208 | 172,954,402 | RGD:6480464 | CTD | |
| G | DMPK | dystrophia myotonica-protein kinase |
|
multiple interactions | ISO | 19 | 46,272,975 | 46,285,815 | RGD:6480464 | CTD | |
| G | DNAH11 | dynein, axonemal, heavy chain 11 |
|
multiple interactions | ISO | 7 | 21,582,833 | 21,941,457 | RGD:6480464 | CTD | |
| G | DNAH12 | dynein, axonemal, heavy chain 12 |
|
multiple interactions | ISO | 3 | 57,327,727 | 57,530,071 | RGD:6480464 | CTD | |
| G | DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 |
|
multiple interactions | ISO | 10 | 22,045,477 | 22,292,650 | RGD:6480464 | CTD | |
| G | DNAJC10 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
multiple interactions | ISO | 2 | 183,580,999 | 183,643,255 | RGD:6480464 | CTD | |
| G | DNAJC19 | DnaJ (Hsp40) homolog, subfamily C, member 19 |
|
multiple interactions | ISO | 3 | 180,701,497 | 180,707,562 | RGD:6480464 | CTD | |
| G | DNM2 | dynamin 2 |
|
multiple interactions | ISO | 19 | 10,828,729 | 10,942,586 | RGD:6480464 | CTD | |
| G | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
|
affects expression | EXP | 19 | 10,244,022 | 10,305,755 | RGD:6480464 | CTD | |
| G | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
|
affects activity | ISO | 19 | 10,244,022 | 10,305,755 | RGD:6480464 | CTD | |
| G | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions | ISO | 19 | 10,244,022 | 10,305,755 | RGD:6480464 | CTD | |
| G | DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha |
|
affects expression | EXP | 2 | 25,455,830 | 25,565,459 | RGD:6480464 | CTD | |
| G | DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha |
|
multiple interactions | ISO | 2 | 25,455,830 | 25,565,459 | RGD:6480464 | CTD | |
| G | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta |
|
affects expression | EXP | 20 | 31,350,191 | 31,397,162 | RGD:6480464 | CTD | |
| G | DNPEP | aspartyl aminopeptidase |
|
multiple interactions | ISO | 2 | 220,238,180 | 220,252,662 | RGD:6480464 | CTD | |
| G | DOC2B | double C2-like domains, beta |
|
multiple interactions | ISO | 17 | 6,009 | 31,420 | RGD:6480464 | CTD | |
| G | DOCK6 | dedicator of cytokinesis 6 |
|
multiple interactions | ISO | 19 | 11,309,969 | 11,373,168 | RGD:6480464 | CTD | |
| G | DOLK | dolichol kinase |
|
multiple interactions | ISO | 9 | 131,707,809 | 131,710,012 | RGD:6480464 | CTD | |
| G | DOLPP1 | dolichyl pyrophosphate phosphatase 1 |
|
multiple interactions | ISO | 9 | 131,843,383 | 131,852,717 | RGD:6480464 | CTD | |
| G | DPT | dermatopontin |
|
affects expression | EXP | 1 | 168,664,695 | 168,698,442 | RGD:6480464 | CTD | |
| G | DPYSL4 | dihydropyrimidinase-like 4 |
|
multiple interactions | ISO | 10 | 134,000,414 | 134,019,280 | RGD:6480464 | CTD | |
| G | DRD4 | dopamine receptor D4 |
|
multiple interactions | ISO | 11 | 637,305 | 640,706 | RGD:6480464 | CTD | |
| G | DST | dystonin |
|
multiple interactions | ISO | 6 6 6 |
56,322,785 56,535,286 56,713,863 |
56,507,694 56,708,082 56,820,047 |
RGD:6480464 | CTD | |
| G | DTD1 | D-tyrosyl-tRNA deacylase 1 |
|
multiple interactions | ISO | 20 | 18,568,556 | 18,744,561 | RGD:6480464 | CTD | |
| G | DTNA | dystrobrevin, alpha |
|
multiple interactions | ISO | 18 | 32,073,254 | 32,471,808 | RGD:6480464 | CTD | |
| G | DTX3 | deltex homolog 3 (Drosophila) |
|
multiple interactions | ISO | 12 | 57,998,604 | 58,003,583 | RGD:6480464 | CTD | |
| G | DUOXA1 | dual oxidase maturation factor 1 |
|
multiple interactions | ISO | 15 | 45,409,685 | 45,422,057 | RGD:6480464 | CTD | |
| G | DUS1L | dihydrouridine synthase 1-like (S. cerevisiae) |
|
multiple interactions | ISO | 17 | 80,015,748 | 80,023,697 | RGD:6480464 | CTD | |
| G | DUS3L | dihydrouridine synthase 3-like (S. cerevisiae) |
|
multiple interactions | ISO | 19 | 5,785,151 | 5,791,249 | RGD:6480464 | CTD | |
| G | DUSP1 | dual specificity phosphatase 1 |
|
multiple interactions | ISO | 5 | 172,195,093 | 172,198,203 | RGD:6480464 | CTD | |
| G | DUSP10 | dual specificity phosphatase 10 |
|
multiple interactions | ISO | 1 | 221,874,764 | 221,915,516 | RGD:6480464 | CTD | |
| G | DUSP11 | dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) |
|
multiple interactions | ISO | 2 | 73,989,325 | 74,007,284 | RGD:6480464 | CTD | |
| G | DUSP14 | dual specificity phosphatase 14 |
|
multiple interactions | ISO | 17 | 35,849,951 | 35,873,588 | RGD:6480464 | CTD | |
| G | DUSP2 | dual specificity phosphatase 2 |
|
multiple interactions | ISO | 2 | 96,808,908 | 96,811,179 | RGD:6480464 | CTD | |
| G | DUSP26 | dual specificity phosphatase 26 (putative) |
|
multiple interactions | ISO | 8 | 33,448,851 | 33,457,439 | RGD:6480464 | CTD | |
| G | DUSP4 | dual specificity phosphatase 4 |
|
multiple interactions | ISO | 8 | 29,190,579 | 29,208,267 | RGD:6480464 | CTD | |
| G | DUSP9 | dual specificity phosphatase 9 |
|
multiple interactions | ISO | X | 152,907,897 | 152,916,781 | RGD:6480464 | CTD | |
| G | DVL2 | dishevelled, dsh homolog 2 (Drosophila) |
|
multiple interactions | ISO | 17 | 7,128,661 | 7,137,863 | RGD:6480464 | CTD | |
| G | DYM | dymeclin |
|
multiple interactions | ISO | 18 | 46,570,172 | 46,987,079 | RGD:6480464 | CTD | |
| G | DYNC2LI1 | dynein, cytoplasmic 2, light intermediate chain 1 |
|
multiple interactions | ISO | 2 | 44,001,178 | 44,037,149 | RGD:6480464 | CTD | |
| G | DYNLL1 | dynein, light chain, LC8-type 1 |
|
multiple interactions | ISO | 12 | 120,907,660 | 120,936,298 | RGD:6480464 | CTD | |
| G | DYNLL2 | dynein, light chain, LC8-type 2 |
|
multiple interactions | ISO | 17 | 56,160,780 | 56,167,618 | RGD:6480464 | CTD | |
| G | DYNLT1 | dynein, light chain, Tctex-type 1 |
|
multiple interactions | ISO | 6 | 159,057,506 | 159,065,804 | RGD:6480464 | CTD | |
| G | DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
|
multiple interactions | ISO | 21 | 38,739,859 | 38,887,679 | RGD:6480464 | CTD | |
| G | DYRK3 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
|
multiple interactions | ISO | 1 | 206,808,881 | 206,822,542 | RGD:6480464 | CTD | |
| G | DZIP1L | DAZ interacting protein 1-like |
|
multiple interactions | ISO | 3 | 137,780,827 | 137,834,451 | RGD:6480464 | CTD | |
| G | E2F1 | E2F transcription factor 1 |
|
multiple interactions | ISO | 20 | 32,263,292 | 32,274,210 | RGD:6480464 | CTD | |
| G | EAF2 | ELL associated factor 2 |
|
multiple interactions | ISO | 3 | 121,554,034 | 121,605,373 | RGD:6480464 | CTD | |
| G | EBI3 | Epstein-Barr virus induced 3 |
|
multiple interactions | ISO | 19 | 4,229,540 | 4,237,525 | RGD:6480464 | CTD | |
| G | EBPL | emopamil binding protein-like |
|
multiple interactions | ISO | 13 | 50,234,810 | 50,265,623 | RGD:6480464 | CTD | |
| G | ECE2 | endothelin converting enzyme 2 |
|
multiple interactions | ISO | 3 | 183,967,445 | 184,010,819 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
multiple interactions | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECHDC1 | enoyl CoA hydratase domain containing 1 |
|
multiple interactions | ISO | 6 | 127,609,857 | 127,664,754 | RGD:6480464 | CTD | |
| G | EDN2 | endothelin 2 |
|
multiple interactions | EXP | 1 | 41,944,446 | 41,950,344 | RGD:6480464 | CTD | |
| G | EDNRB | endothelin receptor type B |
|
multiple interactions | ISO | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:6480464 | CTD | |
| G | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions | ISO | 6 | 74,225,473 | 74,230,755 | RGD:6480464 | CTD | |
| G | EEF1G | eukaryotic translation elongation factor 1 gamma |
|
multiple interactions | ISO | 11 | 62,327,073 | 62,341,460 | RGD:6480464 | CTD | |
| G | EEF2K | eukaryotic elongation factor-2 kinase |
|
multiple interactions | ISO | 16 | 22,217,592 | 22,300,066 | RGD:6480464 | CTD | |
| G | EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 |
|
multiple interactions | ISO | 11 | 65,633,912 | 65,640,405 | RGD:6480464 | CTD | |
| G | EFHC1 | EF-hand domain (C-terminal) containing 1 |
|
multiple interactions | ISO | 6 | 52,284,994 | 52,360,583 | RGD:6480464 | CTD | |
| G | EFHD1 | EF-hand domain family, member D1 |
|
multiple interactions | ISO | 2 | 233,470,767 | 233,547,491 | RGD:6480464 | CTD | |
| G | EFNA1 | ephrin-A1 |
|
multiple interactions | ISO | 1 | 155,100,349 | 155,107,386 | RGD:6480464 | CTD | |
| G | EFNA2 | ephrin-A2 |
|
multiple interactions | ISO | 19 | 1,286,153 | 1,301,430 | RGD:6480464 | CTD | |
| G | EFNA3 | ephrin-A3 |
|
multiple interactions | ISO | 1 | 155,051,348 | 155,060,014 | RGD:6480464 | CTD | |
| G | EFNA5 | ephrin-A5 |
|
multiple interactions | ISO | 5 | 106,712,590 | 107,006,596 | RGD:6480464 | CTD | |
| G | EFNB2 | ephrin-B2 |
|
multiple interactions | ISO | 13 | 107,142,079 | 107,187,388 | RGD:6480464 | CTD | |
| G | EFR3B | EFR3 homolog B (S. cerevisiae) |
|
multiple interactions | ISO | 2 | 25,264,973 | 25,382,004 | RGD:6480464 | CTD | |
| G | EGLN3 | egl nine homolog 3 (C. elegans) |
|
multiple interactions | ISO | 14 | 34,393,421 | 34,420,284 | RGD:6480464 | CTD | |
| G | EGR1 | early growth response 1 |
|
multiple interactions | ISO | 5 | 137,801,181 | 137,805,004 | RGD:6480464 | CTD | |
| G | EGR2 | early growth response 2 |
|
multiple interactions | ISO | 10 | 64,571,756 | 64,578,927 | RGD:6480464 | CTD | |
| G | EGR3 | early growth response 3 |
|
multiple interactions | ISO | 8 | 22,545,174 | 22,550,815 | RGD:6480464 | CTD | |
| G | EHBP1L1 | EH domain binding protein 1-like 1 |
|
multiple interactions | ISO | 11 | 65,343,509 | 65,360,116 | RGD:6480464 | CTD | |
| G | EHD3 | EH-domain containing 3 |
|
multiple interactions | ISO | 2 | 31,456,880 | 31,491,260 | RGD:6480464 | CTD | |
| G | EHF | ets homologous factor |
|
multiple interactions | ISO | 11 | 34,642,588 | 34,684,835 | RGD:6480464 | CTD | |
| G | EID1 | EP300 interacting inhibitor of differentiation 1 |
|
multiple interactions | ISO | 15 | 49,170,290 | 49,172,380 | RGD:6480464 | CTD | |
| G | EID2 | EP300 interacting inhibitor of differentiation 2 |
|
multiple interactions | ISO | 19 | 40,029,446 | 40,030,838 | RGD:6480464 | CTD | |
| G | EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 |
|
multiple interactions | ISO | 2 | 88,856,259 | 88,927,094 | RGD:6480464 | CTD | |
| G | EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa |
|
multiple interactions | ISO | 2 | 27,587,219 | 27,593,324 | RGD:6480464 | CTD | |
| G | EIF3F | eukaryotic translation initiation factor 3, subunit F |
|
multiple interactions | ISO | 11 | 8,008,867 | 8,017,718 | RGD:6480464 | CTD | |
| G | EIF3M | eukaryotic translation initiation factor 3, subunit M |
|
multiple interactions | ISO | 11 | 32,605,313 | 32,624,037 | RGD:6480464 | CTD | |
| G | EIF4B | eukaryotic translation initiation factor 4B |
|
multiple interactions | ISO | 12 | 53,400,062 | 53,435,993 | RGD:6480464 | CTD | |
| G | EIF4E2 | eukaryotic translation initiation factor 4E family member 2 |
|
multiple interactions | ISO | 2 | 233,415,357 | 233,433,920 | RGD:6480464 | CTD | |
| G | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 |
|
multiple interactions | ISO | 10 | 72,163,861 | 72,188,374 | RGD:6480464 | CTD | |
| G | EIF4G3 | eukaryotic translation initiation factor 4 gamma, 3 |
|
multiple interactions | ISO | 1 | 21,132,785 | 21,503,381 | RGD:6480464 | CTD | |
| G | EIF4H | eukaryotic translation initiation factor 4H |
|
multiple interactions | ISO | 7 | 73,588,706 | 73,611,429 | RGD:6480464 | CTD | |
| G | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
|
multiple interactions | ISO | 1 | 201,979,690 | 201,986,316 | RGD:6480464 | CTD | |
| G | ELFN1 | extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
|
multiple interactions | ISO | 7 | 1,748,798 | 1,787,590 | RGD:6480464 | CTD | |
| G | ELL2 | elongation factor, RNA polymerase II, 2 |
|
multiple interactions | ISO | 5 | 95,220,802 | 95,297,775 | RGD:6480464 | CTD | |
| G | ELN | elastin |
|
multiple interactions | ISO | 7 | 73,442,427 | 73,484,237 | RGD:6480464 | CTD | |
| G | ELOVL6 | ELOVL fatty acid elongase 6 |
|
multiple interactions | ISO | 4 | 110,970,229 | 111,119,820 | RGD:6480464 | CTD | |
| G | ELOVL7 | ELOVL fatty acid elongase 7 |
|
multiple interactions | ISO | 5 | 60,047,616 | 60,140,101 | RGD:6480464 | CTD | |
| G | EMB | embigin |
|
multiple interactions | ISO | 5 | 49,692,031 | 49,737,234 | RGD:6480464 | CTD | |
| G | EMILIN2 | elastin microfibril interfacer 2 |
|
multiple interactions | ISO | 18 | 2,847,028 | 2,914,090 | RGD:6480464 | CTD | |
| G | EMILIN3 | elastin microfibril interfacer 3 |
|
multiple interactions | ISO | 20 | 39,988,606 | 39,995,498 | RGD:6480464 | CTD | |
| G | EML1 | echinoderm microtubule associated protein like 1 |
|
multiple interactions | ISO | 14 | 100,259,745 | 100,408,397 | RGD:6480464 | CTD | |
| G | EMP1 | epithelial membrane protein 1 |
|
multiple interactions | ISO | 12 | 13,349,602 | 13,369,708 | RGD:6480464 | CTD | |
| G | EMP2 | epithelial membrane protein 2 |
|
multiple interactions | ISO | 16 | 10,622,279 | 10,674,539 | RGD:6480464 | CTD | |
| G | EMX2 | empty spiracles homeobox 2 |
|
multiple interactions | ISO | 10 | 119,301,956 | 119,309,057 | RGD:6480464 | CTD | |
| G | ENAH | enabled homolog (Drosophila) |
|
multiple interactions | ISO | 1 | 225,674,534 | 225,840,845 | RGD:6480464 | CTD | |
| G | ENC1 | ectodermal-neural cortex 1 (with BTB domain) |
|
multiple interactions | ISO | 5 | 73,923,231 | 73,937,249 | RGD:6480464 | CTD | |
| G | ENDOD1 | endonuclease domain containing 1 |
|
multiple interactions | ISO | 11 | 94,822,974 | 94,865,815 | RGD:6480464 | CTD | |
| G | ENOX1 | ecto-NOX disulfide-thiol exchanger 1 |
|
multiple interactions | ISO | 13 | 43,787,661 | 44,361,116 | RGD:6480464 | CTD | |
| G | ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
multiple interactions | ISO | 6 | 131,958,442 | 132,068,550 | RGD:6480464 | CTD | |
| G | ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 |
|
multiple interactions | ISO | 9 | 139,942,550 | 139,948,503 | RGD:6480464 | CTD | |
| G | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 |
|
multiple interactions | ISO | 14 | 74,433,172 | 74,486,026 | RGD:6480464 | CTD | |
| G | EPAS1 | endothelial PAS domain protein 1 |
|
multiple interactions | ISO | 2 | 46,524,541 | 46,613,842 | RGD:6480464 | CTD | |
| G | EPB41L1 | erythrocyte membrane protein band 4.1-like 1 |
|
multiple interactions | ISO | 20 | 34,679,426 | 34,820,721 | RGD:6480464 | CTD | |
| G | EPB41L4A | erythrocyte membrane protein band 4.1 like 4A |
|
multiple interactions | ISO | 5 | 111,498,315 | 111,755,010 | RGD:6480464 | CTD | |
| G | EPC2 | enhancer of polycomb homolog 2 (Drosophila) |
|
multiple interactions | ISO | 2 | 149,402,560 | 149,545,136 | RGD:6480464 | CTD | |
| G | EPCAM | epithelial cell adhesion molecule |
|
multiple interactions | ISO | 2 | 47,596,287 | 47,614,167 | RGD:6480464 | CTD | |
| G | EPDR1 | ependymin related protein 1 (zebrafish) |
|
multiple interactions | ISO | 7 | 37,960,163 | 37,991,543 | RGD:6480464 | CTD | |
| G | EPHB1 | EPH receptor B1 |
|
multiple interactions | ISO | 3 | 134,514,099 | 134,979,309 | RGD:6480464 | CTD | |
| G | EPHB6 | EPH receptor B6 |
|
affects expression | EXP | 7 | 142,552,792 | 142,568,847 | RGD:6480464 | CTD | |
| G | EPHX3 | epoxide hydrolase 3 |
|
multiple interactions | ISO | 19 | 15,337,730 | 15,343,858 | RGD:6480464 | CTD | |
| G | EPN2 | epsin 2 |
|
multiple interactions | ISO | 17 | 19,140,690 | 19,240,028 | RGD:6480464 | CTD | |
| G | EPS15 | epidermal growth factor receptor pathway substrate 15 |
|
multiple interactions | ISO | 1 | 51,819,935 | 51,984,995 | RGD:6480464 | CTD | |
| G | EPS8L3 | EPS8-like 3 |
|
multiple interactions | ISO | 1 | 110,292,702 | 110,306,644 | RGD:6480464 | CTD | |
| G | EPSTI1 | epithelial stromal interaction 1 (breast) |
|
multiple interactions | ISO | 13 | 43,460,524 | 43,566,407 | RGD:6480464 | CTD | |
| G | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
multiple interactions | ISO | 17 | 37,844,393 | 37,884,915 | RGD:6480464 | CTD | |
| G | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions | ISO | 12 | 56,473,809 | 56,497,291 | RGD:6480464 | CTD | |
| G | ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
|
multiple interactions | ISO | 19 | 45,910,591 | 45,927,177 | RGD:6480464 | CTD | |
| G | ERCC6 | excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
multiple interactions | ISO | 10 | 50,664,491 | 50,747,147 | RGD:6480464 | CTD | |
| G | ERCC6L | excision repair cross-complementing rodent repair deficiency, complementation group 6-like |
|
multiple interactions | ISO | X | 71,424,507 | 71,458,858 | RGD:6480464 | CTD | |
| G | ERGIC1 | endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
|
multiple interactions | ISO | 5 | 172,261,223 | 172,379,688 | RGD:6480464 | CTD | |
| G | ERI1 | exoribonuclease 1 |
|
multiple interactions | ISO | 8 | 8,860,314 | 8,890,849 | RGD:6480464 | CTD | |
| G | ERN1 | endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions | ISO | 17 | 62,120,390 | 62,207,502 | RGD:6480464 | CTD | |
| G | ERO1LB | ERO1-like beta (S. cerevisiae) |
|
multiple interactions | ISO | 1 | 236,378,422 | 236,445,339 | RGD:6480464 | CTD | |
| G | ESCO1 | establishment of cohesion 1 homolog 1 (S. cerevisiae) |
|
multiple interactions | ISO | 18 | 19,109,262 | 19,180,693 | RGD:6480464 | CTD | |
| G | ESPL1 | extra spindle pole bodies homolog 1 (S. cerevisiae) |
|
multiple interactions | ISO | 12 | 53,662,083 | 53,687,427 | RGD:6480464 | CTD | |
| G | ESPN | espin |
|
multiple interactions | ISO | 1 | 6,484,848 | 6,521,004 | RGD:6480464 | CTD | |
| G | ESYT1 | extended synaptotagmin-like protein 1 |
|
multiple interactions | ISO | 12 | 56,521,986 | 56,538,460 | RGD:6480464 | CTD | |
| G | ETF1 | eukaryotic translation termination factor 1 |
|
multiple interactions | ISO | 5 | 137,841,782 | 137,878,989 | RGD:6480464 | CTD | |
| G | ETFA | electron-transfer-flavoprotein, alpha polypeptide |
|
multiple interactions | ISO | 15 | 76,508,628 | 76,603,810 | RGD:6480464 | CTD | |
| G | ETNK1 | ethanolamine kinase 1 |
|
multiple interactions | ISO | 12 | 22,778,076 | 22,843,608 | RGD:6480464 | CTD | |
| G | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
affects expression | EXP | 21 | 40,177,231 | 40,196,879 | RGD:6480464 | CTD | |
| G | EVC2 | Ellis van Creveld syndrome 2 |
|
multiple interactions | ISO | 4 | 5,564,146 | 5,711,275 | RGD:6480464 | CTD | |
| G | EVI2A | ecotropic viral integration site 2A |
|
multiple interactions | ISO | 17 | 29,643,428 | 29,648,767 | RGD:6480464 | CTD | |
| G | EVI2B | ecotropic viral integration site 2B |
|
multiple interactions | ISO | 17 | 29,630,788 | 29,641,130 | RGD:6480464 | CTD | |
| G | EVL | Enah/Vasp-like |
|
multiple interactions | ISO | 14 | 100,531,751 | 100,610,573 | RGD:6480464 | CTD | |
| G | EVPL | envoplakin |
|
multiple interactions | ISO | 17 | 74,002,927 | 74,023,507 | RGD:6480464 | CTD | |
| G | EVX1 | even-skipped homeobox 1 |
|
multiple interactions | ISO | 7 | 27,282,164 | 27,286,192 | RGD:6480464 | CTD | |
| G | EXD1 | exonuclease 3'-5' domain containing 1 |
|
multiple interactions | ISO | 15 | 41,474,926 | 41,522,895 | RGD:6480464 | CTD | |
| G | EXO1 | exonuclease 1 |
|
multiple interactions | ISO | 1 | 242,011,493 | 242,053,241 | RGD:6480464 | CTD | |
| G | EXOSC8 | exosome component 8 |
|
multiple interactions | ISO | 13 | 37,574,678 | 37,583,751 | RGD:6480464 | CTD | |
| G | FAM126A | family with sequence similarity 126, member A |
|
affects expression | EXP | 7 | 22,980,878 | 23,053,770 | RGD:6480464 | CTD | |
| G | FARS2 | phenylalanyl-tRNA synthetase 2, mitochondrial |
|
multiple interactions | ISO | 6 | 5,261,584 | 5,771,816 | RGD:6480464 | CTD | |
| G | FAS | Fas (TNF receptor superfamily, member 6) |
|
affects expression | EXP | 10 | 90,750,288 | 90,775,542 | RGD:6480464 | CTD | |
| G | FGA | fibrinogen alpha chain |
|
increases expression | EXP | 4 | 155,504,280 | 155,511,897 | RGD:6480464 | CTD | |
| G | FGF8 | fibroblast growth factor 8 (androgen-induced) |
|
multiple interactions | ISO | 10 | 103,529,887 | 103,540,126 | RGD:6480464 | CTD | |
| G | FHL1 | four and a half LIM domains 1 |
|
affects expression | EXP | X | 135,228,861 | 135,293,518 | RGD:6480464 | CTD | |
| G | FKBP4 | FK506 binding protein 4, 59kDa |
|
multiple interactions | ISO | 12 | 2,904,108 | 2,914,589 | RGD:6480464 | CTD | |
| G | FLNB | filamin B, beta |
|
multiple interactions | ISO | 3 | 57,994,127 | 58,157,982 | RGD:6480464 | CTD | |
| G | FLNC | filamin C, gamma |
|
multiple interactions | ISO | 7 | 128,470,483 | 128,499,328 | RGD:6480464 | CTD | |
| G | FLRT2 | fibronectin leucine rich transmembrane protein 2 |
|
multiple interactions | ISO | 14 | 85,996,488 | 86,094,270 | RGD:6480464 | CTD | |
| G | FLT1 | fms-related tyrosine kinase 1 |
|
multiple interactions | ISO | 13 | 28,874,483 | 29,069,265 | RGD:6480464 | CTD | |
| G | FLT3LG | fms-related tyrosine kinase 3 ligand |
|
multiple interactions | ISO | 19 | 49,977,466 | 49,989,488 | RGD:6480464 | CTD | |
| G | FMN2 | formin 2 |
|
multiple interactions | ISO | 1 | 240,255,185 | 240,638,489 | RGD:6480464 | CTD | |
| G | FNBP1 | formin binding protein 1 |
|
multiple interactions | ISO | 9 | 132,649,466 | 132,805,473 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
affects expression | EXP | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
decreases expression | EXP | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
affects abundance | ISO | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
increases uptake | ISO | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
multiple interactions | ISO | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
decreases expression | ISO | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOLR2 | folate receptor 2 (fetal) |
|
multiple interactions | EXP | 11 | 71,927,819 | 71,932,994 | RGD:6480464 | CTD | |
| G | FOLR2 | folate receptor 2 (fetal) |
|
decreases expression | EXP | 11 | 71,927,819 | 71,932,994 | RGD:6480464 | CTD | |
| G | FOLR2 | folate receptor 2 (fetal) |
|
multiple interactions | ISO | 11 | 71,927,819 | 71,932,994 | RGD:6480464 | CTD | |
| G | FOLR2 | folate receptor 2 (fetal) |
|
multiple interactions | ISO | 11 | 71,927,819 | 71,932,994 | RGD:6480464 | CTD | |
| G | FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
multiple interactions | ISO | 16 | 86,600,857 | 86,602,539 | RGD:6480464 | CTD | |
| G | FOXP4 | forkhead box P4 |
|
multiple interactions | ISO | 6 | 41,514,164 | 41,570,122 | RGD:6480464 | CTD | |
| G | FPGS | folylpolyglutamate synthase |
|
affects expression | EXP | 9 | 130,565,154 | 130,576,556 | RGD:6480464 | CTD | |
| G | FTL | ferritin, light polypeptide |
|
affects expression | EXP | 19 | 49,468,566 | 49,470,136 | RGD:6480464 | CTD | |
| G | GAS6 | growth arrest-specific 6 |
|
affects expression | EXP | 13 | 114,523,522 | 114,567,046 | RGD:6480464 | CTD | |
| G | GDF15 | growth differentiation factor 15 |
|
multiple interactions | EXP | 19 | 18,496,968 | 18,499,986 | RGD:6480464 | CTD | |
| G | GDPD3 | glycerophosphodiester phosphodiesterase domain containing 3 |
|
affects expression | EXP | 16 | 30,116,131 | 30,124,878 | RGD:6480464 | CTD | |
| G | GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
affects expression | EXP | 8 | 63,927,638 | 63,951,610 | RGD:6480464 | CTD | |
| G | GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
multiple interactions | ISO | 8 | 63,927,638 | 63,951,610 | RGD:6480464 | CTD | |
| G | GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
increases hydrolysis | ISO | 8 | 63,927,638 | 63,951,610 | RGD:6480464 | CTD | |
| G | GGT1 | gamma-glutamyltransferase 1 |
|
affects activity | ISO | 22 | 24,979,718 | 25,024,972 | RGD:6480464 | CTD | |
| G | GJA1 | gap junction protein, alpha 1, 43kDa |
|
affects expression | EXP | 6 | 121,756,745 | 121,770,873 | RGD:6480464 | CTD | |
| G | GLI3 | GLI family zinc finger 3 |
|
multiple interactions | ISO | 7 | 42,000,547 | 42,276,618 | RGD:6480464 | CTD | |
| G | GNMT | glycine N-methyltransferase |
|
affects activity | ISO | 6 | 42,928,500 | 42,931,618 | RGD:6480464 | CTD | |
| G | GNMT | glycine N-methyltransferase |
|
multiple interactions | ISO | 6 | 42,928,500 | 42,931,618 | RGD:6480464 | CTD | |
| G | GPT | glutamic-pyruvate transaminase (alanine aminotransferase) |
|
decreases expression | EXP | 8 | 145,729,465 | 145,732,555 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
affects activity | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
affects expression | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GUK1 | guanylate kinase 1 |
|
multiple interactions | EXP | 1 | 228,327,785 | 228,336,656 | RGD:6480464 | CTD | |
| G | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) |
|
increases expression | ISO | 7 | 81,331,444 | 81,399,452 | RGD:6480464 | CTD | |
| G | HHEX | hematopoietically expressed homeobox |
|
multiple interactions | ISO | 10 | 94,449,681 | 94,455,408 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression | ISO | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) |
|
affects expression | EXP | 12 | 117,299,027 | 117,319,232 | RGD:6480464 | CTD | |
| G | HSPA9 | heat shock 70kDa protein 9 (mortalin) |
|
affects expression | ISO | 5 | 137,890,571 | 137,911,318 | RGD:6480464 | CTD | |
| G | HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) |
|
affects expression | EXP | 1 | 16,340,523 | 16,345,285 | RGD:6480464 | CTD | |
| G | ICOS | inducible T-cell co-stimulator |
|
multiple interactions | ISO | 2 | 204,801,471 | 204,826,300 | RGD:6480464 | CTD | |
| G | ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
|
affects expression | EXP | 20 | 30,193,086 | 30,194,318 | RGD:6480464 | CTD | |
| G | IFITM1 | interferon induced transmembrane protein 1 |
|
multiple interactions | EXP | 11 | 313,991 | 315,272 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | EXP | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFNLR1 | interferon, lambda receptor 1 |
|
multiple interactions | ISO | 1 | 24,480,647 | 24,513,765 | RGD:6480464 | CTD | |
| G | IGF1R | insulin-like growth factor 1 receptor |
|
multiple interactions | EXP | 15 | 99,192,761 | 99,507,759 | RGD:6480464 | CTD | |
| G | IGF1R | insulin-like growth factor 1 receptor |
|
decreases expression | EXP | 15 | 99,192,761 | 99,507,759 | RGD:6480464 | CTD | |
| G | IGFBP5 | insulin-like growth factor binding protein 5 |
|
affects expression | EXP | 2 | 217,536,828 | 217,560,272 | RGD:6480464 | CTD | |
| G | IL13RA1 | interleukin 13 receptor, alpha 1 |
|
multiple interactions | ISO | X | 117,861,559 | 117,928,496 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1R2 | interleukin 1 receptor, type II |
|
multiple interactions | ISO | 2 | 102,608,306 | 102,644,885 | RGD:6480464 | CTD | |
| G | IL1RAPL2 | interleukin 1 receptor accessory protein-like 2 |
|
multiple interactions | ISO | X | 103,810,996 | 105,011,822 | RGD:6480464 | CTD | |
| G | IL1RL2 | interleukin 1 receptor-like 2 |
|
multiple interactions | ISO | 2 | 102,803,433 | 102,855,811 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
multiple interactions | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
affects expression | EXP | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL20RB | interleukin 20 receptor beta |
|
multiple interactions | ISO | 3 | 136,676,707 | 136,729,927 | RGD:6480464 | CTD | |
| G | IL4I1 | interleukin 4 induced 1 |
|
multiple interactions | ISO | 19 | 50,392,911 | 50,432,796 | RGD:6480464 | CTD | |
| G | IL4R | interleukin 4 receptor |
|
multiple interactions | ISO | 16 | 27,325,230 | 27,376,099 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
multiple interactions | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6R | interleukin 6 receptor |
|
multiple interactions | ISO | 1 | 154,377,669 | 154,441,926 | RGD:6480464 | CTD | |
| G | IL7R | interleukin 7 receptor |
|
multiple interactions | ISO | 5 | 35,856,977 | 35,879,705 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
decreases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | ILDR1 | immunoglobulin-like domain containing receptor 1 |
|
multiple interactions | ISO | 3 | 121,706,170 | 121,741,127 | RGD:6480464 | CTD | |
| G | ILF3 | interleukin enhancer binding factor 3, 90kDa |
|
multiple interactions | ISO | 19 | 10,764,937 | 10,803,095 | RGD:6480464 | CTD | |
| G | IMPA1 | inositol(myo)-1(or 4)-monophosphatase 1 |
|
multiple interactions | ISO | 8 | 82,569,151 | 82,598,589 | RGD:6480464 | CTD | |
| G | IMPAD1 | inositol monophosphatase domain containing 1 |
|
multiple interactions | ISO | 8 | 57,870,488 | 57,906,430 | RGD:6480464 | CTD | |
| G | IMPDH1 | IMP (inosine 5'-monophosphate) dehydrogenase 1 |
|
multiple interactions | ISO | 7 | 128,032,331 | 128,050,036 | RGD:6480464 | CTD | |
| G | INCENP | inner centromere protein antigens 135/155kDa |
|
multiple interactions | ISO | 11 | 61,891,445 | 61,920,635 | RGD:6480464 | CTD | |
| G | ING1 | inhibitor of growth family, member 1 |
|
multiple interactions | ISO | 13 | 111,364,970 | 111,373,421 | RGD:6480464 | CTD | |
| G | ING2 | inhibitor of growth family, member 2 |
|
multiple interactions | ISO | 4 | 184,426,220 | 184,432,249 | RGD:6480464 | CTD | |
| G | INHBB | inhibin, beta B |
|
multiple interactions | ISO | 2 | 121,103,719 | 121,109,383 | RGD:6480464 | CTD | |
| G | INO80 | INO80 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 15 | 41,271,078 | 41,408,340 | RGD:6480464 | CTD | |
| G | INPP5A | inositol polyphosphate-5-phosphatase, 40kDa |
|
multiple interactions | ISO | 10 | 134,351,353 | 134,596,984 | RGD:6480464 | CTD | |
| G | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa |
|
multiple interactions | ISO | 2 2 |
233,925,036 234,054,795 |
233,995,880 234,116,549 |
RGD:6480464 | CTD | |
| G | INPPL1 | inositol polyphosphate phosphatase-like 1 |
|
multiple interactions | ISO | 11 | 71,935,882 | 71,950,191 | RGD:6480464 | CTD | |
| G | INSIG1 | insulin induced gene 1 |
|
increases expression | EXP | 7 | 155,089,486 | 155,101,945 | RGD:6480464 | CTD | |
| G | INSL6 | insulin-like 6 |
|
multiple interactions | ISO | 9 | 5,163,863 | 5,185,618 | RGD:6480464 | CTD | |
| G | INSM1 | insulinoma-associated 1 |
|
multiple interactions | ISO | 20 | 20,348,765 | 20,351,593 | RGD:6480464 | CTD | |
| G | INSM2 | insulinoma-associated 2 |
|
multiple interactions | ISO | 14 | 36,003,248 | 36,006,260 | RGD:6480464 | CTD | |
| G | INSRR | insulin receptor-related receptor |
|
multiple interactions | ISO | 1 | 156,810,665 | 156,828,712 | RGD:6480464 | CTD | |
| G | INTS1 | integrator complex subunit 1 |
|
multiple interactions | ISO | 7 | 1,509,913 | 1,544,018 | RGD:6480464 | CTD | |
| G | INTS6 | integrator complex subunit 6 |
|
multiple interactions | ISO | 13 | 51,935,701 | 52,027,275 | RGD:6480464 | CTD | |
| G | INTU | inturned planar cell polarity protein |
|
multiple interactions | ISO | 4 | 128,554,087 | 128,637,934 | RGD:6480464 | CTD | |
| G | IP6K1 | inositol hexakisphosphate kinase 1 |
|
multiple interactions | ISO | 3 | 49,761,728 | 49,823,973 | RGD:6480464 | CTD | |
| G | IPMK | inositol polyphosphate multikinase |
|
multiple interactions | ISO | 10 | 59,951,278 | 60,027,694 | RGD:6480464 | CTD | |
| G | IPO9 | importin 9 |
|
multiple interactions | ISO | 1 | 201,798,288 | 201,853,422 | RGD:6480464 | CTD | |
| G | IPP | intracisternal A particle-promoted polypeptide |
|
multiple interactions | ISO | 1 | 46,159,996 | 46,216,485 | RGD:6480464 | CTD | |
| G | IQCG | IQ motif containing G |
|
multiple interactions | ISO | 3 | 197,615,946 | 197,686,886 | RGD:6480464 | CTD | |
| G | IQGAP1 | IQ motif containing GTPase activating protein 1 |
|
multiple interactions | ISO | 15 | 90,931,473 | 91,045,475 | RGD:6480464 | CTD | |
| G | IQGAP3 | IQ motif containing GTPase activating protein 3 |
|
multiple interactions | ISO | 1 | 156,495,197 | 156,542,396 | RGD:6480464 | CTD | |
| G | IRAK3 | interleukin-1 receptor-associated kinase 3 |
|
multiple interactions | ISO | 12 | 66,582,978 | 66,648,402 | RGD:6480464 | CTD | |
| G | IRF2BP1 | interferon regulatory factor 2 binding protein 1 |
|
multiple interactions | ISO | 19 | 46,386,866 | 46,389,376 | RGD:6480464 | CTD | |
| G | IRF8 | interferon regulatory factor 8 |
|
multiple interactions | ISO | 16 | 85,932,774 | 85,956,212 | RGD:6480464 | CTD | |
| G | IRGC | immunity-related GTPase family, cinema |
|
multiple interactions | ISO | 19 | 44,220,214 | 44,224,173 | RGD:6480464 | CTD | |
| G | IRS1 | insulin receptor substrate 1 |
|
multiple interactions | ISO | 2 | 227,596,033 | 227,663,506 | RGD:6480464 | CTD | |
| G | IRX2 | iroquois homeobox 2 |
|
multiple interactions | ISO | 5 | 2,746,279 | 2,751,769 | RGD:6480464 | CTD | |
| G | IRX5 | iroquois homeobox 5 |
|
multiple interactions | ISO | 16 | 54,965,111 | 54,968,397 | RGD:6480464 | CTD | |
| G | IRX6 | iroquois homeobox 6 |
|
multiple interactions | ISO | 16 | 55,358,471 | 55,364,672 | RGD:6480464 | CTD | |
| G | ISCA1 | iron-sulfur cluster assembly 1 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 9 | 88,879,461 | 88,897,490 | RGD:6480464 | CTD | |
| G | ISL1 | ISL LIM homeobox 1 |
|
multiple interactions | ISO | 5 | 50,678,958 | 50,690,564 | RGD:6480464 | CTD | |
| G | ISL2 | ISL LIM homeobox 2 |
|
multiple interactions | ISO | 15 | 76,629,147 | 76,634,816 | RGD:6480464 | CTD | |
| G | ISLR | immunoglobulin superfamily containing leucine-rich repeat |
|
multiple interactions | ISO | 15 | 74,466,087 | 74,469,212 | RGD:6480464 | CTD | |
| G | ISLR2 | immunoglobulin superfamily containing leucine-rich repeat 2 |
|
multiple interactions | ISO | 15 | 74,421,715 | 74,429,143 | RGD:6480464 | CTD | |
| G | ISY1 | ISY1 splicing factor homolog (S. cerevisiae) |
|
multiple interactions | ISO | 3 | 128,846,259 | 128,880,073 | RGD:6480464 | CTD | |
| G | ISYNA1 | inositol-3-phosphate synthase 1 |
|
multiple interactions | ISO | 19 | 18,545,198 | 18,549,111 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
affects expression | EXP | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
|
affects expression | EXP | 2 | 182,321,619 | 182,402,474 | RGD:6480464 | CTD | |
| G | ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
affects expression | EXP | 12 | 54,789,045 | 54,813,050 | RGD:6480464 | CTD | |
| G | ITGA6 | integrin, alpha 6 |
|
affects expression | EXP | 2 | 173,292,314 | 173,371,181 | RGD:6480464 | CTD | |
| G | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
|
affects expression | EXP | 10 | 33,189,246 | 33,247,293 | RGD:6480464 | CTD | |
| G | ITGB8 | integrin, beta 8 |
|
multiple interactions | ISO | 7 | 20,370,725 | 20,455,382 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | EXP | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | KAT6B | K(lysine) acetyltransferase 6B |
|
multiple interactions | ISO | 10 | 76,586,171 | 76,792,380 | RGD:6480464 | CTD | |
| G | KCTD13 | potassium channel tetramerisation domain containing 13 |
|
multiple interactions | ISO | 16 | 29,917,657 | 29,937,545 | RGD:6480464 | CTD | |
| G | KCTD15 | potassium channel tetramerisation domain containing 15 |
|
multiple interactions | ISO | 19 | 34,287,751 | 34,306,666 | RGD:6480464 | CTD | |
| G | KCTD17 | potassium channel tetramerisation domain containing 17 |
|
multiple interactions | ISO | 22 | 37,447,779 | 37,459,430 | RGD:6480464 | CTD | |
| G | KDELR3 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
|
multiple interactions | ISO | 22 | 38,864,083 | 38,879,445 | RGD:6480464 | CTD | |
| G | KDM2B | lysine (K)-specific demethylase 2B |
|
multiple interactions | ISO | 12 | 121,866,899 | 122,018,920 | RGD:6480464 | CTD | |
| G | KLHDC7A | kelch domain containing 7A |
|
multiple interactions | ISO | 1 | 18,807,424 | 18,812,493 | RGD:6480464 | CTD | |
| G | KLHL12 | kelch-like family member 12 |
|
multiple interactions | ISO | 1 | 202,860,230 | 202,896,371 | RGD:6480464 | CTD | |
| G | KLK3 | kallikrein-related peptidase 3 |
|
multiple interactions | ISO | 19 | 51,358,171 | 51,364,020 | RGD:6480464 | CTD | |
| G | KLRD1 | killer cell lectin-like receptor subfamily D, member 1 |
|
multiple interactions | ISO | 12 | 10,457,050 | 10,469,850 | RGD:6480464 | CTD | |
| G | KNCN | kinocilin |
|
multiple interactions | ISO | 1 | 47,011,316 | 47,016,887 | RGD:6480464 | CTD | |
| G | KNTC1 | kinetochore associated 1 |
|
affects expression | EXP | 12 | 123,011,809 | 123,110,947 | RGD:6480464 | CTD | |
| G | KPNA4 | karyopherin alpha 4 (importin alpha 3) |
|
multiple interactions | ISO | 3 | 160,212,783 | 160,283,376 | RGD:6480464 | CTD | |
| G | KPNB1 | karyopherin (importin) beta 1 |
|
multiple interactions | ISO | 17 | 45,727,275 | 45,761,004 | RGD:6480464 | CTD | |
| G | KRI1 | KRI1 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 19 | 10,663,761 | 10,676,702 | RGD:6480464 | CTD | |
| G | KRT14 | keratin 14 |
|
decreases expression | EXP | 17 | 39,738,531 | 39,743,147 | RGD:6480464 | CTD | |
| G | KRT19 | keratin 19 |
|
multiple interactions | ISO | 17 | 39,679,869 | 39,684,641 | RGD:6480464 | CTD | |
| G | LGALS3 | lectin, galactoside-binding, soluble, 3 |
|
increases expression | ISO | 14 | 55,595,935 | 55,612,148 | RGD:6480464 | CTD | |
| G | MALL | mal, T-cell differentiation protein-like |
|
affects expression | EXP | 2 | 110,841,447 | 110,874,143 | RGD:6480464 | CTD | |
| G | MAP1B | microtubule-associated protein 1B |
|
affects expression | EXP | 5 | 71,403,118 | 71,505,397 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | EXP | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | EXP | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases activity | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | EXP | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | EXP | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
increases activity | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
multiple interactions | ISO | 10 | 49,609,687 | 49,643,183 | RGD:6480464 | CTD | |
| G | MBD2 | methyl-CpG binding domain protein 2 |
|
affects expression | EXP | 18 | 51,677,971 | 51,751,158 | RGD:6480464 | CTD | |
| G | MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) |
|
affects expression | EXP | 1 | 150,547,027 | 150,552,214 | RGD:6480464 | CTD | |
| G | MCU | mitochondrial calcium uniporter |
|
multiple interactions | ISO | 10 | 74,451,889 | 74,647,452 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
affects expression | EXP | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | MEF2A | myocyte enhancer factor 2A |
|
multiple interactions | ISO | 15 | 100,106,133 | 100,256,630 | RGD:6480464 | CTD | |
| G | MET | met proto-oncogene (hepatocyte growth factor receptor) |
|
multiple interactions | ISO | 7 | 116,312,459 | 116,438,440 | RGD:6480464 | CTD | |
| G | MET | met proto-oncogene (hepatocyte growth factor receptor) |
|
increases expression | ISO | 7 | 116,312,459 | 116,438,440 | RGD:6480464 | CTD | |
| G | MGLL | monoglyceride lipase |
|
affects expression | EXP | 3 | 127,407,905 | 127,542,093 | RGD:6480464 | CTD | |
| G | MGMT | O-6-methylguanine-DNA methyltransferase |
|
multiple interactions | EXP | 10 | 131,265,454 | 131,565,783 | RGD:6480464 | CTD | |
| G | MICA | MHC class I polypeptide-related sequence A |
|
affects expression | EXP | 6 | 31,367,561 | 31,383,090 | RGD:6480464 | CTD | |
| G | MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
affects expression | EXP | 22 | 24,236,565 | 24,237,409 | RGD:6480464 | CTD | |
| G | MME | membrane metallo-endopeptidase |
|
affects expression | EXP | 3 | 154,797,436 | 154,901,518 | RGD:6480464 | CTD | |
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases activity | ISO | 11 | 102,660,641 | 102,668,966 | RGD:6480464 | CTD | |
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions | ISO | 11 | 102,660,641 | 102,668,966 | RGD:6480464 | CTD | |
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression | ISO | 11 | 102,660,641 | 102,668,966 | RGD:6480464 | CTD | |
| G | MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
|
affects expression | EXP | 11 | 102,706,528 | 102,714,342 | RGD:6480464 | CTD | |
| G | MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) |
|
increases expression | ISO | 11 | 102,391,239 | 102,401,478 | RGD:6480464 | CTD | |
| G | MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) |
|
multiple interactions | ISO | 11 | 102,391,239 | 102,401,478 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
multiple interactions | EXP | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects expression | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
multiple interactions | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
decreases abundance | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
multiple interactions | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects abundance | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects metabolic processing | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
multiple interactions | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects metabolic processing | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects abundance | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects abundance | EXP | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase |
|
affects expression | EXP | 1 | 236,958,581 | 237,067,281 | RGD:6480464 | CTD | |
| G | MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
affects expression | EXP | 5 | 7,869,217 | 7,901,237 | RGD:6480464 | CTD | |
| G | MUC1 | mucin 1, cell surface associated |
|
affects expression | EXP | 1 | 155,158,300 | 155,162,706 | RGD:6480464 | CTD | |
| G | MUC13 | mucin 13, cell surface associated |
|
multiple interactions | ISO | 3 | 124,624,289 | 124,653,595 | RGD:6480464 | CTD | |
| G | MUSTN1 | musculoskeletal, embryonic nuclear protein 1 |
|
multiple interactions | ISO | 3 | 52,867,131 | 52,869,235 | RGD:6480464 | CTD | |
| G | MXI1 | MAX interactor 1, dimerization protein |
|
multiple interactions | ISO | 10 | 111,967,363 | 112,047,123 | RGD:6480464 | CTD | |
| G | MYB | v-myb myeloblastosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 6 | 135,502,453 | 135,540,311 | RGD:6480464 | CTD | |
| G | MYO10 | myosin X |
|
affects expression | EXP | 5 | 16,662,016 | 16,936,385 | RGD:6480464 | CTD | |
| G | MYO1F | myosin IF |
|
multiple interactions | ISO | 19 | 8,585,674 | 8,642,331 | RGD:6480464 | CTD | |
| G | MYO5A | myosin VA (heavy chain 12, myoxin) |
|
multiple interactions | ISO | 15 | 52,599,480 | 52,821,247 | RGD:6480464 | CTD | |
| G | MYO6 | myosin VI |
|
multiple interactions | ISO | 6 | 76,458,909 | 76,629,254 | RGD:6480464 | CTD | |
| G | MYOF | myoferlin |
|
multiple interactions | ISO | 10 | 95,066,186 | 95,242,074 | RGD:6480464 | CTD | |
| G | MYOM1 | myomesin 1 |
|
multiple interactions | ISO | 18 | 3,066,805 | 3,220,106 | RGD:6480464 | CTD | |
| G | MYOZ1 | myozenin 1 |
|
multiple interactions | ISO | 10 | 75,391,370 | 75,401,515 | RGD:6480464 | CTD | |
| G | MZF1 | myeloid zinc finger 1 |
|
multiple interactions | ISO | 19 | 59,073,284 | 59,084,942 | RGD:6480464 | CTD | |
| G | N4BP2L1 | NEDD4 binding protein 2-like 1 |
|
multiple interactions | ISO | 13 | 32,974,860 | 33,002,315 | RGD:6480464 | CTD | |
| G | NAB1 | NGFI-A binding protein 1 (EGR1 binding protein 1) |
|
multiple interactions | ISO | 2 | 191,513,848 | 191,557,492 | RGD:6480464 | CTD | |
| G | NACC2 | NACC family member 2, BEN and BTB (POZ) domain containing |
|
multiple interactions | ISO | 9 | 138,898,383 | 138,987,131 | RGD:6480464 | CTD | |
| G | NAE1 | NEDD8 activating enzyme E1 subunit 1 |
|
multiple interactions | ISO | 16 | 66,836,781 | 66,864,879 | RGD:6480464 | CTD | |
| G | NANP | N-acetylneuraminic acid phosphatase |
|
multiple interactions | ISO | 20 | 25,593,571 | 25,604,648 | RGD:6480464 | CTD | |
| G | NANS | N-acetylneuraminic acid synthase |
|
multiple interactions | ISO | 9 | 100,818,959 | 100,845,365 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
multiple interactions | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha |
|
multiple interactions | ISO | 19 | 47,990,891 | 48,018,515 | RGD:6480464 | CTD | |
| G | NAPSA | napsin A aspartic peptidase |
|
multiple interactions | ISO | 19 | 50,861,734 | 50,868,931 | RGD:6480464 | CTD | |
| G | NARF | nuclear prelamin A recognition factor |
|
multiple interactions | ISO | 17 | 80,416,060 | 80,446,143 | RGD:6480464 | CTD | |
| G | NARS2 | asparaginyl-tRNA synthetase 2, mitochondrial (putative) |
|
multiple interactions | ISO | 11 | 78,147,007 | 78,285,909 | RGD:6480464 | CTD | |
| G | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
decreases activity | EXP | 8 | 18,027,971 | 18,081,198 | RGD:6480464 | CTD | |
| G | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
increases acetylation | EXP | 8 | 18,027,971 | 18,081,198 | RGD:6480464 | CTD | |
| G | NCAM1 | neural cell adhesion molecule 1 |
|
affects expression | EXP | 11 | 112,831,969 | 113,149,158 | RGD:6480464 | CTD | |
| G | NCAPH | non-SMC condensin I complex, subunit H |
|
multiple interactions | ISO | 2 | 97,001,484 | 97,041,274 | RGD:6480464 | CTD | |
| G | NCF1 | neutrophil cytosolic factor 1 |
|
multiple interactions | EXP | 7 | 74,188,309 | 74,203,659 | RGD:6480464 | CTD | |
| G | NDST1 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
affects expression | EXP | 5 | 149,887,674 | 149,937,773 | RGD:6480464 | CTD | |
| G | NEUROG2 | neurogenin 2 |
|
multiple interactions | ISO | 4 | 113,434,672 | 113,437,328 | RGD:6480464 | CTD | |
| G | NEXN | nexilin (F actin binding protein) |
|
multiple interactions | ISO | 1 | 78,354,200 | 78,409,580 | RGD:6480464 | CTD | |
| G | NF1 | neurofibromin 1 |
|
multiple interactions | ISO | 17 | 29,421,945 | 29,704,695 | RGD:6480464 | CTD | |
| G | NFASC | neurofascin |
|
multiple interactions | ISO | 1 | 204,797,782 | 204,991,950 | RGD:6480464 | CTD | |
| G | NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions | ISO | 18 | 77,155,772 | 77,289,323 | RGD:6480464 | CTD | |
| G | NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
multiple interactions | ISO | 20 | 50,003,494 | 50,179,370 | RGD:6480464 | CTD | |
| G | NFATC2IP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein |
|
multiple interactions | ISO | 16 | 28,962,318 | 28,977,786 | RGD:6480464 | CTD | |
| G | NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 |
|
multiple interactions | ISO | 17 | 46,125,686 | 46,138,907 | RGD:6480464 | CTD | |
| G | NFIA | nuclear factor I/A |
|
multiple interactions | ISO | 1 | 61,542,946 | 61,928,460 | RGD:6480464 | CTD | |
| G | NFIL3 | nuclear factor, interleukin 3 regulated |
|
multiple interactions | ISO | 9 | 94,171,327 | 94,186,144 | RGD:6480464 | CTD | |
| G | NFIX | nuclear factor I/X (CCAAT-binding transcription factor) |
|
multiple interactions | ISO | 19 | 13,106,584 | 13,209,610 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects expression | EXP | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
affects expression | EXP | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | EXP | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
multiple interactions | ISO | 3 | 101,546,834 | 101,579,869 | RGD:6480464 | CTD | |
| G | NFYB | nuclear transcription factor Y, beta |
|
multiple interactions | ISO | 12 | 104,510,858 | 104,532,040 | RGD:6480464 | CTD | |
| G | NGFRAP1 | nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
multiple interactions | ISO | X | 102,631,268 | 102,633,001 | RGD:6480464 | CTD | |
| G | NME4 | NME/NM23 nucleoside diphosphate kinase 4 |
|
affects expression | EXP | 16 | 447,192 | 450,754 | RGD:6480464 | CTD | |
| G | NME5 | NME/NM23 family member 5 |
|
multiple interactions | ISO | 5 | 137,450,861 | 137,475,132 | RGD:6480464 | CTD | |
| G | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 |
|
multiple interactions | ISO | 1 | 183,217,372 | 183,387,634 | RGD:6480464 | CTD | |
| G | NMT2 | N-myristoyltransferase 2 |
|
multiple interactions | ISO | 10 | 15,147,771 | 15,210,695 | RGD:6480464 | CTD | |
| G | NOB1 | NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 16 | 69,775,774 | 69,788,829 | RGD:6480464 | CTD | |
| G | NODAL | nodal growth differentiation factor |
|
multiple interactions | ISO | 10 | 72,191,692 | 72,201,465 | RGD:6480464 | CTD | |
| G | NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions | ISO | 16 | 67,204,405 | 67,209,643 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOTCH4 | notch 4 |
|
multiple interactions | EXP | 6 | 32,162,620 | 32,191,844 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
affects expression | ISO | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
affects metabolic processing | ISO | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NREP | neuronal regeneration related protein |
|
affects expression | EXP | 5 | 111,065,000 | 111,312,628 | RGD:6480464 | CTD | |
| G | NTHL1 | nth endonuclease III-like 1 (E. coli) |
|
multiple interactions | EXP | 16 | 2,089,816 | 2,097,867 | RGD:6480464 | CTD | |
| G | NTN4 | netrin 4 |
|
affects expression | EXP | 12 | 96,051,583 | 96,184,536 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
increases cleavage | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PASK | PAS domain containing serine/threonine kinase |
|
multiple interactions | ISO | 2 | 242,045,514 | 242,089,394 | RGD:6480464 | CTD | |
| G | PATL1 | protein associated with topoisomerase II homolog 1 (yeast) |
|
multiple interactions | ISO | 11 | 59,404,189 | 59,436,511 | RGD:6480464 | CTD | |
| G | PAX2 | paired box 2 |
|
multiple interactions | ISO | 10 | 102,505,468 | 102,589,698 | RGD:6480464 | CTD | |
| G | PAX3 | paired box 3 |
|
multiple interactions | ISO | 2 | 223,064,606 | 223,163,715 | RGD:6480464 | CTD | |
| G | PAX6 | paired box 6 |
|
multiple interactions | ISO | 11 | 31,806,340 | 31,839,509 | RGD:6480464 | CTD | |
| G | PBLD | phenazine biosynthesis-like protein domain containing |
|
affects expression | ISO | 10 | 70,042,417 | 70,092,684 | RGD:6480464 | CTD | |
| G | PBLD | phenazine biosynthesis-like protein domain containing |
|
affects expression | ISO | 10 | 70,042,417 | 70,092,684 | RGD:6480464 | CTD | |
| G | PBX3 | pre-B-cell leukemia homeobox 3 |
|
multiple interactions | ISO | 9 | 128,509,617 | 128,729,656 | RGD:6480464 | CTD | |
| G | PCBP1 | poly(rC) binding protein 1 |
|
multiple interactions | ISO | 2 | 70,314,585 | 70,316,335 | RGD:6480464 | CTD | |
| G | PCDHB7 | protocadherin beta 7 |
|
multiple interactions | ISO | 5 | 140,552,243 | 140,555,957 | RGD:6480464 | CTD | |
| G | PCGF1 | polycomb group ring finger 1 |
|
multiple interactions | ISO | 2 | 74,732,170 | 74,734,821 | RGD:6480464 | CTD | |
| G | PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
multiple interactions | ISO | 14 | 24,563,483 | 24,573,339 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
increases expression | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCNP | PEST proteolytic signal containing nuclear protein |
|
multiple interactions | ISO | 3 | 101,293,042 | 101,313,281 | RGD:6480464 | CTD | |
| G | PCOLCE2 | procollagen C-endopeptidase enhancer 2 |
|
affects expression | EXP | 3 | 142,536,702 | 142,608,045 | RGD:6480464 | CTD | |
| G | PCSK1N | proprotein convertase subtilisin/kexin type 1 inhibitor |
|
multiple interactions | ISO | X | 48,689,506 | 48,693,960 | RGD:6480464 | CTD | |
| G | PCSK5 | proprotein convertase subtilisin/kexin type 5 |
|
multiple interactions | ISO | 9 | 78,505,560 | 78,977,255 | RGD:6480464 | CTD | |
| G | PDGFA | platelet-derived growth factor alpha polypeptide |
|
affects expression | EXP | 7 | 536,895 | 559,481 | RGD:6480464 | CTD | |
| G | PFDN5 | prefoldin subunit 5 |
|
multiple interactions | EXP | 12 | 53,689,235 | 53,693,234 | RGD:6480464 | CTD | |
| G | PGK1 | phosphoglycerate kinase 1 |
|
affects expression | EXP | X | 77,359,666 | 77,382,324 | RGD:6480464 | CTD | |
| G | PGRMC2 | progesterone receptor membrane component 2 |
|
affects expression | EXP | 4 | 129,190,392 | 129,209,984 | RGD:6480464 | CTD | |
| G | PHLDB1 | pleckstrin homology-like domain, family B, member 1 |
|
multiple interactions | ISO | 11 | 118,477,213 | 118,528,748 | RGD:6480464 | CTD | |
| G | PHTF2 | putative homeodomain transcription factor 2 |
|
multiple interactions | ISO | 7 | 77,428,109 | 77,586,821 | RGD:6480464 | CTD | |
| G | PIAS1 | protein inhibitor of activated STAT, 1 |
|
multiple interactions | ISO | 15 | 68,346,572 | 68,480,413 | RGD:6480464 | CTD | |
| G | PIF1 | PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
|
multiple interactions | ISO | 15 | 65,107,831 | 65,117,838 | RGD:6480464 | CTD | |
| G | PIGA | phosphatidylinositol glycan anchor biosynthesis, class A |
|
multiple interactions | ISO | X | 15,337,573 | 15,353,676 | RGD:6480464 | CTD | |
| G | PIGB | phosphatidylinositol glycan anchor biosynthesis, class B |
|
multiple interactions | ISO | 15 | 55,611,133 | 55,647,846 | RGD:6480464 | CTD | |
| G | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
affects expression | EXP | 5 | 67,511,584 | 67,597,649 | RGD:6480464 | CTD | |
| G | PIM1 | pim-1 oncogene |
|
multiple interactions | ISO | 6 | 37,137,922 | 37,143,204 | RGD:6480464 | CTD | |
| G | PLAT | plasminogen activator, tissue |
|
multiple interactions | ISO | 8 | 42,032,236 | 42,065,194 | RGD:6480464 | CTD | |
| G | PLAU | plasminogen activator, urokinase |
|
affects expression | EXP | 10 | 75,670,862 | 75,677,259 | RGD:6480464 | CTD | |
| G | PLAUR | plasminogen activator, urokinase receptor |
|
affects expression | EXP | 19 | 44,150,247 | 44,174,498 | RGD:6480464 | CTD | |
| G | PMP22 | peripheral myelin protein 22 |
|
multiple interactions | ISO | 17 | 15,133,096 | 15,168,644 | RGD:6480464 | CTD | |
| G | PNKD | paroxysmal nonkinesigenic dyskinesia |
|
multiple interactions | ISO | 2 | 219,135,115 | 219,211,516 | RGD:6480464 | CTD | |
| G | PNPLA2 | patatin-like phospholipase domain containing 2 |
|
multiple interactions | ISO | 11 | 818,901 | 825,573 | RGD:6480464 | CTD | |
| G | PNPLA3 | patatin-like phospholipase domain containing 3 |
|
multiple interactions | ISO | 22 | 44,319,619 | 44,343,448 | RGD:6480464 | CTD | |
| G | PNPLA8 | patatin-like phospholipase domain containing 8 |
|
multiple interactions | ISO | 7 | 108,110,866 | 108,168,605 | RGD:6480464 | CTD | |
| G | PNRC1 | proline-rich nuclear receptor coactivator 1 |
|
multiple interactions | ISO | 6 | 89,790,429 | 89,794,879 | RGD:6480464 | CTD | |
| G | PODXL | podocalyxin-like |
|
affects expression | EXP | 7 | 131,185,021 | 131,241,376 | RGD:6480464 | CTD | |
| G | POLA1 | polymerase (DNA directed), alpha 1, catalytic subunit |
|
multiple interactions | ISO | X | 24,712,064 | 25,015,103 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
affects expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
affects metabolic processing | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PRDX6 | peroxiredoxin 6 |
|
affects expression | ISO | 1 | 173,446,486 | 173,457,946 | RGD:6480464 | CTD | |
| G | PRKDC | protein kinase, DNA-activated, catalytic polypeptide |
|
affects expression | EXP | 8 | 48,685,669 | 48,872,743 | RGD:6480464 | CTD | |
| G | PRR16 | proline rich 16 |
|
affects expression | EXP | 5 | 119,800,019 | 120,022,965 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
multiple interactions | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
decreases expression | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
decreases expression | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
multiple interactions | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
multiple interactions | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
increases expression | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
increases expression | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTHLH | parathyroid hormone-like hormone |
|
increases expression | ISO | 12 | 28,111,017 | 28,124,916 | RGD:6480464 | CTD | |
| G | PTK6 | protein tyrosine kinase 6 |
|
affects expression | EXP | 20 | 62,159,766 | 62,168,723 | RGD:6480464 | CTD | |
| G | PTPN18 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
|
multiple interactions | ISO | 2 | 131,113,580 | 131,132,982 | RGD:6480464 | CTD | |
| G | PTPN3 | protein tyrosine phosphatase, non-receptor type 3 |
|
multiple interactions | ISO | 9 | 112,137,974 | 112,260,593 | RGD:6480464 | CTD | |
| G | PTPN7 | protein tyrosine phosphatase, non-receptor type 7 |
|
multiple interactions | ISO | 1 | 202,116,141 | 202,130,716 | RGD:6480464 | CTD | |
| G | PTPRD | protein tyrosine phosphatase, receptor type, D |
|
multiple interactions | ISO | 9 | 8,314,246 | 10,612,723 | RGD:6480464 | CTD | |
| G | PURG | purine-rich element binding protein G |
|
multiple interactions | ISO | 8 | 30,853,321 | 30,891,231 | RGD:6480464 | CTD | |
| G | PUS3 | pseudouridylate synthase 3 |
|
multiple interactions | ISO | 11 | 125,763,380 | 125,773,116 | RGD:6480464 | CTD | |
| G | PYGB | phosphorylase, glycogen; brain |
|
multiple interactions | ISO | 20 | 25,228,706 | 25,278,648 | RGD:6480464 | CTD | |
| G | RACGAP1P | Rac GTPase activating protein 1 pseudogene |
|
affects expression | EXP | 12 | 45,456,401 | 45,459,194 | RGD:6480464 | CTD | |
| G | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 |
|
affects expression | EXP | 3 | 12,625,100 | 12,705,700 | RGD:6480464 | CTD | |
| G | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 |
|
affects expression | EXP | 5 | 86,564,070 | 86,687,743 | RGD:6480464 | CTD | |
| G | RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
|
affects expression | EXP | 9 | 36,036,910 | 36,124,452 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RFC1 | replication factor C (activator 1) 1, 145kDa |
|
multiple interactions | ISO | 4 | 39,289,069 | 39,368,001 | RGD:6480464 | CTD | |
| G | RHOC | ras homolog family member C |
|
multiple interactions | EXP | 1 | 113,243,749 | 113,250,025 | RGD:6480464 | CTD | |
| G | RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
|
multiple interactions | ISO | 14 | 21,423,630 | 21,424,594 | RGD:6480464 | CTD | |
| G | RNASE3 | ribonuclease, RNase A family, 3 |
|
multiple interactions | ISO | 14 | 21,359,562 | 21,360,507 | RGD:6480464 | CTD | |
| G | RPA3 | replication protein A3, 14kDa |
|
affects expression | EXP | 7 | 7,676,575 | 7,758,238 | RGD:6480464 | CTD | |
| G | RPS5 | ribosomal protein S5 |
|
multiple interactions | EXP | 19 | 58,898,636 | 58,906,171 | RGD:6480464 | CTD | |
| G | RPUSD1 | RNA pseudouridylate synthase domain containing 1 |
|
multiple interactions | ISO | 16 | 834,974 | 838,383 | RGD:6480464 | CTD | |
| G | RRAD | Ras-related associated with diabetes |
|
multiple interactions | ISO | 16 | 66,955,582 | 66,959,439 | RGD:6480464 | CTD | |
| G | RRAGC | Ras-related GTP binding C |
|
multiple interactions | ISO | 1 | 39,305,005 | 39,325,340 | RGD:6480464 | CTD | |
| G | RRAGD | Ras-related GTP binding D |
|
multiple interactions | ISO | 6 | 90,074,335 | 90,121,995 | RGD:6480464 | CTD | |
| G | RRBP1 | ribosome binding protein 1 |
|
multiple interactions | ISO | 20 | 17,594,323 | 17,662,928 | RGD:6480464 | CTD | |
| G | RSF1 | remodeling and spacing factor 1 |
|
multiple interactions | ISO | 11 | 77,377,274 | 77,531,880 | RGD:6480464 | CTD | |
| G | S100A10 | S100 calcium binding protein A10 |
|
affects expression | EXP | 1 | 151,955,386 | 151,966,714 | RGD:6480464 | CTD | |
| G | S100A4 | S100 calcium binding protein A4 |
|
affects expression | EXP | 1 | 153,516,095 | 153,518,282 | RGD:6480464 | CTD | |
| G | SAT1 | spermidine/spermine N1-acetyltransferase 1 |
|
increases expression | EXP | X | 23,801,275 | 23,804,327 | RGD:6480464 | CTD | |
| G | SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
|
multiple interactions | ISO | 5 | 9,035,138 | 9,546,233 | RGD:6480464 | CTD | |
| G | SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
affects expression | EXP | 18 | 61,554,939 | 61,571,124 | RGD:6480464 | CTD | |
| G | SHMT1 | serine hydroxymethyltransferase 1 (soluble) |
|
affects expression | EXP | 17 | 18,231,187 | 18,266,856 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
affects expression | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
decreases expression | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
increases uptake | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
affects uptake | ISO | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 |
|
decreases expression | ISO | 11 | 62,744,069 | 62,752,495 | RGD:6480464 | CTD | |
| G | SLC22A8 | solute carrier family 22 (organic anion transporter), member 8 |
|
decreases expression | ISO | 11 | 62,760,296 | 62,783,317 | RGD:6480464 | CTD | |
| G | SLC24A3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
|
multiple interactions | ISO | 20 | 19,193,290 | 19,703,541 | RGD:6480464 | CTD | |
| G | SLC25A1 | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
|
multiple interactions | ISO | 22 | 19,163,088 | 19,166,338 | RGD:6480464 | CTD | |
| G | SLC25A24 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
|
multiple interactions | ISO | 1 | 108,677,344 | 108,742,980 | RGD:6480464 | CTD | |
| G | SLC25A25 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
|
multiple interactions | ISO | 9 | 130,830,479 | 130,871,537 | RGD:6480464 | CTD | |
| G | SLC25A27 | solute carrier family 25, member 27 |
|
multiple interactions | ISO | 6 | 46,620,652 | 46,645,927 | RGD:6480464 | CTD | |
| G | SLC25A29 | solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
|
multiple interactions | ISO | 14 | 100,757,453 | 100,772,860 | RGD:6480464 | CTD | |
| G | SLC25A36 | solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
multiple interactions | ISO | 3 | 140,660,662 | 140,698,785 | RGD:6480464 | CTD | |
| G | SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions | ISO | 4 | 186,064,417 | 186,071,538 | RGD:6480464 | CTD | |
| G | SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions | ISO | 3 | 170,714,137 | 170,744,768 | RGD:6480464 | CTD | |
| G | SLC2A6 | solute carrier family 2 (facilitated glucose transporter), member 6 |
|
multiple interactions | ISO | 9 | 136,336,216 | 136,344,276 | RGD:6480464 | CTD | |
| G | SLC30A9 | solute carrier family 30 (zinc transporter), member 9 |
|
multiple interactions | ISO | 4 | 41,992,523 | 42,089,551 | RGD:6480464 | CTD | |
| G | SLC32A1 | solute carrier family 32 (GABA vesicular transporter), member 1 |
|
multiple interactions | ISO | 20 | 37,353,105 | 37,358,015 | RGD:6480464 | CTD | |
| G | SLC35A3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
|
multiple interactions | ISO | 1 | 100,435,540 | 100,489,006 | RGD:6480464 | CTD | |
| G | SLC35B3 | solute carrier family 35, member B3 |
|
multiple interactions | ISO | 6 | 8,413,301 | 8,435,794 | RGD:6480464 | CTD | |
| G | SLC35D1 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
multiple interactions | ISO | 1 | 67,465,015 | 67,520,080 | RGD:6480464 | CTD | |
| G | SLC35D3 | solute carrier family 35, member D3 |
|
multiple interactions | ISO | 6 | 137,243,402 | 137,246,777 | RGD:6480464 | CTD | |
| G | SLC35E1 | solute carrier family 35, member E1 |
|
multiple interactions | ISO | 19 | 16,660,648 | 16,683,193 | RGD:6480464 | CTD | |
| G | SLC35E4 | solute carrier family 35, member E4 |
|
multiple interactions | ISO | 22 | 31,031,793 | 31,043,862 | RGD:6480464 | CTD | |
| G | SLC35F1 | solute carrier family 35, member F1 |
|
multiple interactions | ISO | 6 | 118,228,689 | 118,638,839 | RGD:6480464 | CTD | |
| G | SLC35F2 | solute carrier family 35, member F2 |
|
multiple interactions | ISO | 11 | 107,661,717 | 107,729,914 | RGD:6480464 | CTD | |
| G | SLC36A1 | solute carrier family 36 (proton/amino acid symporter), member 1 |
|
multiple interactions | ISO | 5 | 150,827,163 | 150,871,940 | RGD:6480464 | CTD | |
| G | SLC37A2 | solute carrier family 37 (glycerol-3-phosphate transporter), member 2 |
|
multiple interactions | ISO | 11 | 124,933,013 | 124,960,412 | RGD:6480464 | CTD | |
| G | SLC38A1 | solute carrier family 38, member 1 |
|
multiple interactions | ISO | 12 | 46,576,838 | 46,663,208 | RGD:6480464 | CTD | |
| G | SLC38A5 | solute carrier family 38, member 5 |
|
multiple interactions | ISO | X | 48,316,927 | 48,328,644 | RGD:6480464 | CTD | |
| G | SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
multiple interactions | ISO | 11 | 62,623,484 | 62,656,355 | RGD:6480464 | CTD | |
| G | SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression | EXP | 2 | 190,425,316 | 190,445,537 | RGD:6480464 | CTD | |
| G | SLC41A3 | solute carrier family 41, member 3 |
|
multiple interactions | ISO | 3 | 125,725,200 | 125,820,391 | RGD:6480464 | CTD | |
| G | SLC43A2 | solute carrier family 43, member 2 |
|
multiple interactions | ISO | 17 | 1,477,696 | 1,532,130 | RGD:6480464 | CTD | |
| G | SLC44A3 | solute carrier family 44, member 3 |
|
multiple interactions | ISO | 1 | 95,285,898 | 95,360,803 | RGD:6480464 | CTD | |
| G | SLC44A4 | solute carrier family 44, member 4 |
|
multiple interactions | ISO | 6 | 31,830,969 | 31,846,823 | RGD:6480464 | CTD | |
| G | SLC45A1 | solute carrier family 45, member 1 |
|
multiple interactions | ISO | 1 | 8,384,390 | 8,404,227 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
multiple interactions | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
decreases expression | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases uptake | ISO | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | ISO | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
multiple interactions | ISO | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
|
increases transport | EXP | 17 | 26,721,661 | 26,733,230 | RGD:6480464 | CTD | |
| G | SLC5A1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions | ISO | 22 | 32,439,019 | 32,509,016 | RGD:6480464 | CTD | |
| G | SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
multiple interactions | ISO | X | 152,953,752 | 152,962,048 | RGD:6480464 | CTD | |
| G | SLC6A9 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
multiple interactions | ISO | 1 | 44,462,155 | 44,497,164 | RGD:6480464 | CTD | |
| G | SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions | ISO | 4 | 139,085,248 | 139,163,503 | RGD:6480464 | CTD | |
| G | SLC7A2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
multiple interactions | ISO | 8 | 17,354,597 | 17,428,077 | RGD:6480464 | CTD | |
| G | SLC7A6 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
|
multiple interactions | ISO | 16 | 68,298,419 | 68,335,726 | RGD:6480464 | CTD | |
| G | SLC7A7 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
affects expression | EXP | 14 | 23,242,431 | 23,289,020 | RGD:6480464 | CTD | |
| G | SLC9A3 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
|
multiple interactions | ISO | 5 | 473,334 | 524,549 | RGD:6480464 | CTD | |
| G | SLC9A7 | solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 |
|
multiple interactions | ISO | X | 46,458,686 | 46,618,607 | RGD:6480464 | CTD | |
| G | SLCO3A1 | solute carrier organic anion transporter family, member 3A1 |
|
multiple interactions | ISO | 15 | 92,396,938 | 92,715,665 | RGD:6480464 | CTD | |
| G | SLFN12L | schlafen family member 12-like |
|
multiple interactions | ISO | 17 | 33,801,942 | 33,814,758 | RGD:6480464 | CTD | |
| G | SLIT2 | slit homolog 2 (Drosophila) |
|
multiple interactions | ISO | 4 | 20,255,235 | 20,620,788 | RGD:6480464 | CTD | |
| G | SLIT3 | slit homolog 3 (Drosophila) |
|
multiple interactions | ISO | 5 | 168,093,071 | 168,728,133 | RGD:6480464 | CTD | |
| G | SLITRK4 | SLIT and NTRK-like family, member 4 |
|
multiple interactions | ISO | X | 142,710,595 | 142,723,926 | RGD:6480464 | CTD | |
| G | SLK | STE20-like kinase |
|
multiple interactions | ISO | 10 | 105,727,470 | 105,787,342 | RGD:6480464 | CTD | |
| G | SLTM | SAFB-like, transcription modulator |
|
multiple interactions | ISO | 15 | 59,171,244 | 59,225,852 | RGD:6480464 | CTD | |
| G | SMAD3 | SMAD family member 3 |
|
multiple interactions | ISO | 15 | 67,358,195 | 67,487,533 | RGD:6480464 | CTD | |
| G | SMAD6 | SMAD family member 6 |
|
multiple interactions | ISO | 15 | 66,994,674 | 67,074,338 | RGD:6480464 | CTD | |
| G | SMAD7 | SMAD family member 7 |
|
multiple interactions | ISO | 18 | 46,446,223 | 46,477,081 | RGD:6480464 | CTD | |
| G | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
|
multiple interactions | ISO | 9 | 2,015,342 | 2,193,624 | RGD:6480464 | CTD | |
| G | SMOX | spermine oxidase |
|
multiple interactions | ISO | 20 | 4,129,426 | 4,168,394 | RGD:6480464 | CTD | |
| G | SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal |
|
increases expression | ISO | 11 | 6,411,644 | 6,416,228 | RGD:6480464 | CTD | |
| G | SMPD3 | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
|
multiple interactions | ISO | 16 | 68,392,230 | 68,482,409 | RGD:6480464 | CTD | |
| G | SMPDL3A | sphingomyelin phosphodiesterase, acid-like 3A |
|
multiple interactions | ISO | 6 | 123,109,971 | 123,130,865 | RGD:6480464 | CTD | |
| G | SNAI1 | snail homolog 1 (Drosophila) |
|
multiple interactions | ISO | 20 | 48,599,513 | 48,605,423 | RGD:6480464 | CTD | |
| G | SNAPC3 | small nuclear RNA activating complex, polypeptide 3, 50kDa |
|
multiple interactions | ISO | 9 | 15,422,782 | 15,461,627 | RGD:6480464 | CTD | |
| G | SNRPG | small nuclear ribonucleoprotein polypeptide G |
|
multiple interactions | ISO | 2 | 70,508,510 | 70,520,869 | RGD:6480464 | CTD | |
| G | SNX19 | sorting nexin 19 |
|
multiple interactions | ISO | 11 | 130,745,766 | 130,786,382 | RGD:6480464 | CTD | |
| G | SNX22 | sorting nexin 22 |
|
multiple interactions | ISO | 15 | 64,443,916 | 64,449,680 | RGD:6480464 | CTD | |
| G | SNX9 | sorting nexin 9 |
|
multiple interactions | ISO | 6 | 158,244,294 | 158,366,109 | RGD:6480464 | CTD | |
| G | SOAT1 | sterol O-acyltransferase 1 |
|
multiple interactions | ISO | 1 | 179,262,849 | 179,327,815 | RGD:6480464 | CTD | |
| G | SOBP | sine oculis binding protein homolog (Drosophila) |
|
multiple interactions | ISO | 6 | 107,811,317 | 107,982,513 | RGD:6480464 | CTD | |
| G | SOCS1 | suppressor of cytokine signaling 1 |
|
multiple interactions | ISO | 16 | 11,348,274 | 11,350,039 | RGD:6480464 | CTD | |
| G | SOCS2 | suppressor of cytokine signaling 2 |
|
multiple interactions | ISO | 12 | 93,963,598 | 93,970,521 | RGD:6480464 | CTD | |
| G | SOCS6 | suppressor of cytokine signaling 6 |
|
multiple interactions | ISO | 18 | 67,956,137 | 67,997,434 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
decreases expression | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SORBS3 | sorbin and SH3 domain containing 3 |
|
multiple interactions | ISO | 8 | 22,409,251 | 22,433,008 | RGD:6480464 | CTD | |
| G | SORCS2 | sortilin-related VPS10 domain containing receptor 2 |
|
multiple interactions | ISO | 4 | 7,194,374 | 7,744,564 | RGD:6480464 | CTD | |
| G | SORCS3 | sortilin-related VPS10 domain containing receptor 3 |
|
multiple interactions | ISO | 10 | 106,400,859 | 107,024,993 | RGD:6480464 | CTD | |
| G | SOX1 | SRY (sex determining region Y)-box 1 |
|
multiple interactions | ISO | 13 | 112,721,913 | 112,726,020 | RGD:6480464 | CTD | |
| G | SOX11 | SRY (sex determining region Y)-box 11 |
|
multiple interactions | ISO | 2 | 5,832,799 | 5,841,517 | RGD:6480464 | CTD | |
| G | SOX12 | SRY (sex determining region Y)-box 12 |
|
multiple interactions | ISO | 20 | 306,239 | 310,868 | RGD:6480464 | CTD | |
| G | SOX18 | SRY (sex determining region Y)-box 18 |
|
multiple interactions | ISO | 20 | 62,679,079 | 62,680,979 | RGD:6480464 | CTD | |
| G | SOX3 | SRY (sex determining region Y)-box 3 |
|
multiple interactions | ISO | X | 139,585,152 | 139,587,225 | RGD:6480464 | CTD | |
| G | SOX4 | SRY (sex determining region Y)-box 4 |
|
increases expression | EXP | 6 | 21,593,972 | 21,598,850 | RGD:6480464 | CTD | |
| G | SOX9 | SRY (sex determining region Y)-box 9 |
|
multiple interactions | ISO | 17 | 70,117,161 | 70,122,561 | RGD:6480464 | CTD | |
| G | SP1 | Sp1 transcription factor |
|
multiple interactions | EXP | 12 | 53,773,979 | 53,810,230 | RGD:6480464 | CTD | |
| G | SPACA1 | sperm acrosome associated 1 |
|
multiple interactions | ISO | 6 | 88,757,507 | 88,776,550 | RGD:6480464 | CTD | |
| G | SPAG9 | sperm associated antigen 9 |
|
multiple interactions | ISO | 17 | 49,039,535 | 49,198,226 | RGD:6480464 | CTD | |
| G | SPIC | Spi-C transcription factor (Spi-1/PU.1 related) |
|
multiple interactions | ISO | 12 | 101,870,657 | 101,880,775 | RGD:6480464 | CTD | |
| G | SPINK1 | serine peptidase inhibitor, Kazal type 1 |
|
increases expression | EXP | 5 | 147,204,143 | 147,211,260 | RGD:6480464 | CTD | |
| G | SPINT1 | serine peptidase inhibitor, Kunitz type 1 |
|
multiple interactions | ISO | 15 | 41,136,246 | 41,149,853 | RGD:6480464 | CTD | |
| G | SPIRE2 | spire homolog 2 (Drosophila) |
|
multiple interactions | ISO | 16 | 89,894,907 | 89,937,727 | RGD:6480464 | CTD | |
| G | SPTBN1 | spectrin, beta, non-erythrocytic 1 |
|
multiple interactions | ISO | 2 | 54,683,454 | 54,898,583 | RGD:6480464 | CTD | |
| G | SPTBN2 | spectrin, beta, non-erythrocytic 2 |
|
multiple interactions | ISO | 11 | 66,452,720 | 66,488,870 | RGD:6480464 | CTD | |
| G | STARD13 | StAR-related lipid transfer (START) domain containing 13 |
|
multiple interactions | ISO | 13 | 33,677,272 | 34,250,932 | RGD:6480464 | CTD | |
| G | STAT1 | signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions | ISO | 2 | 191,833,762 | 191,878,976 | RGD:6480464 | CTD | |
| G | STAT4 | signal transducer and activator of transcription 4 |
|
multiple interactions | ISO | 2 | 191,894,302 | 192,016,322 | RGD:6480464 | CTD | |
| G | STK38L | serine/threonine kinase 38 like |
|
multiple interactions | ISO | 12 | 27,397,078 | 27,478,892 | RGD:6480464 | CTD | |
| G | STOX2 | storkhead box 2 |
|
multiple interactions | ISO | 4 | 184,826,509 | 184,938,875 | RGD:6480464 | CTD | |
| G | STRA6 | stimulated by retinoic acid 6 |
|
multiple interactions | ISO | 15 | 74,471,807 | 74,502,046 | RGD:6480464 | CTD | |
| G | STRADB | STE20-related kinase adaptor beta |
|
multiple interactions | ISO | 2 | 202,316,392 | 202,345,574 | RGD:6480464 | CTD | |
| G | STT3B | STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
|
multiple interactions | ISO | 3 | 31,574,491 | 31,677,556 | RGD:6480464 | CTD | |
| G | STX3 | syntaxin 3 |
|
multiple interactions | ISO | 11 | 59,522,532 | 59,573,355 | RGD:6480464 | CTD | |
| G | STX4 | syntaxin 4 |
|
multiple interactions | ISO | 16 | 31,044,903 | 31,051,485 | RGD:6480464 | CTD | |
| G | STXBP5 | syntaxin binding protein 5 (tomosyn) |
|
multiple interactions | ISO | 6 | 147,525,494 | 147,711,612 | RGD:6480464 | CTD | |
| G | STYXL1 | serine/threonine/tyrosine interacting-like 1 |
|
multiple interactions | ISO | 7 | 75,625,655 | 75,677,321 | RGD:6480464 | CTD | |
| G | SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit |
|
multiple interactions | ISO | 3 | 67,410,884 | 67,705,038 | RGD:6480464 | CTD | |
| G | SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 |
|
multiple interactions | ISO | 19 | 49,055,429 | 49,102,684 | RGD:6480464 | CTD | |
| G | SULT4A1 | sulfotransferase family 4A, member 1 |
|
multiple interactions | ISO | 22 | 44,220,387 | 44,258,378 | RGD:6480464 | CTD | |
| G | SUMF1 | sulfatase modifying factor 1 |
|
multiple interactions | ISO | 3 | 4,402,829 | 4,508,966 | RGD:6480464 | CTD | |
| G | SUPT3H | suppressor of Ty 3 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 6 | 44,794,467 | 45,345,788 | RGD:6480464 | CTD | |
| G | SURF2 | surfeit 2 |
|
multiple interactions | ISO | 9 | 136,223,421 | 136,228,040 | RGD:6480464 | CTD | |
| G | TAGLN | transgelin |
|
affects expression | EXP | 11 | 117,070,040 | 117,075,508 | RGD:6480464 | CTD | |
| G | TM4SF1 | transmembrane 4 L six family member 1 |
|
affects expression | EXP | 3 | 149,086,805 | 149,095,568 | RGD:6480464 | CTD | |
| G | TMEM192 | transmembrane protein 192 |
|
multiple interactions | ISO | 4 | 165,997,230 | 166,034,024 | RGD:6480464 | CTD | |
| G | TMEM33 | transmembrane protein 33 |
|
multiple interactions | ISO | 4 | 41,937,137 | 41,962,824 | RGD:6480464 | CTD | |
| G | TMEM39A | transmembrane protein 39A |
|
multiple interactions | ISO | 3 | 119,149,701 | 119,182,471 | RGD:6480464 | CTD | |
| G | TMEM40 | transmembrane protein 40 |
|
multiple interactions | ISO | 3 | 12,775,392 | 12,800,808 | RGD:6480464 | CTD | |
| G | TMEM43 | transmembrane protein 43 |
|
multiple interactions | ISO | 3 | 14,166,440 | 14,185,180 | RGD:6480464 | CTD | |
| G | TMEM45A | transmembrane protein 45A |
|
multiple interactions | ISO | 3 | 100,211,463 | 100,296,285 | RGD:6480464 | CTD | |
| G | TMEM45B | transmembrane protein 45B |
|
multiple interactions | ISO | 11 | 129,685,741 | 129,729,898 | RGD:6480464 | CTD | |
| G | TMEM47 | transmembrane protein 47 |
|
multiple interactions | ISO | X | 34,645,181 | 34,675,405 | RGD:6480464 | CTD | |
| G | TMEM48 | transmembrane protein 48 |
|
multiple interactions | ISO | 1 | 54,231,133 | 54,304,225 | RGD:6480464 | CTD | |
| G | TMEM56 | transmembrane protein 56 |
|
multiple interactions | ISO | 1 | 95,582,894 | 95,663,163 | RGD:6480464 | CTD | |
| G | TMEM57 | transmembrane protein 57 |
|
multiple interactions | ISO | 1 | 25,757,388 | 25,826,700 | RGD:6480464 | CTD | |
| G | TMEM63A | transmembrane protein 63A |
|
multiple interactions | ISO | 1 | 226,033,233 | 226,070,420 | RGD:6480464 | CTD | |
| G | TMEM65 | transmembrane protein 65 |
|
multiple interactions | ISO | 8 | 125,323,159 | 125,384,940 | RGD:6480464 | CTD | |
| G | TMEM71 | transmembrane protein 71 |
|
multiple interactions | ISO | 8 | 133,722,191 | 133,772,914 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b |
|
affects expression | EXP | 8 | 22,877,646 | 22,926,700 | RGD:6480464 | CTD | |
| G | TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A |
|
increases expression | ISO | 16 | 3,070,313 | 3,072,384 | RGD:6480464 | CTD | |
| G | TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 |
|
affects expression | EXP | 1 | 2,487,805 | 2,495,268 | RGD:6480464 | CTD | |
| G | TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 |
|
multiple interactions | ISO | 6 | 47,199,268 | 47,277,680 | RGD:6480464 | CTD | |
| G | TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 |
|
multiple interactions | ISO | 1 | 6,521,211 | 6,526,255 | RGD:6480464 | CTD | |
| G | TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
|
increases expression | ISO | 17 | 7,452,375 | 7,461,207 | RGD:6480464 | CTD | |
| G | TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 |
|
multiple interactions | ISO | 17 | 7,461,609 | 7,464,925 | RGD:6480464 | CTD | |
| G | TNIP1 | TNFAIP3 interacting protein 1 |
|
multiple interactions | ISO | 5 | 150,409,504 | 150,467,221 | RGD:6480464 | CTD | |
| G | TNIP2 | TNFAIP3 interacting protein 2 |
|
multiple interactions | ISO | 4 | 2,743,387 | 2,758,103 | RGD:6480464 | CTD | |
| G | TNK1 | tyrosine kinase, non-receptor, 1 |
|
multiple interactions | ISO | 17 | 7,284,293 | 7,293,093 | RGD:6480464 | CTD | |
| G | TNK2 | tyrosine kinase, non-receptor, 2 |
|
multiple interactions | ISO | 3 | 195,590,236 | 195,635,880 | RGD:6480464 | CTD | |
| G | TNKS1BP1 | tankyrase 1 binding protein 1, 182kDa |
|
multiple interactions | ISO | 11 | 57,067,103 | 57,092,413 | RGD:6480464 | CTD | |
| G | TNNC1 | troponin C type 1 (slow) |
|
multiple interactions | ISO | 3 | 52,485,107 | 52,488,057 | RGD:6480464 | CTD | |
| G | TNNI2 | troponin I type 2 (skeletal, fast) |
|
multiple interactions | ISO | 11 | 1,860,233 | 1,862,910 | RGD:6480464 | CTD | |
| G | TNNT2 | troponin T type 2 (cardiac) |
|
multiple interactions | ISO | 1 | 201,328,142 | 201,346,805 | RGD:6480464 | CTD | |
| G | TNRC6A | trinucleotide repeat containing 6A |
|
multiple interactions | ISO | 16 | 24,741,049 | 24,837,548 | RGD:6480464 | CTD | |
| G | TOE1 | target of EGR1, member 1 (nuclear) |
|
multiple interactions | ISO | 1 | 45,805,342 | 45,809,650 | RGD:6480464 | CTD | |
| G | TOMM20 | translocase of outer mitochondrial membrane 20 homolog (yeast) |
|
multiple interactions | ISO | 1 | 235,272,656 | 235,292,256 | RGD:6480464 | CTD | |
| G | TOMM40 | translocase of outer mitochondrial membrane 40 homolog (yeast) |
|
multiple interactions | ISO | 19 | 45,394,477 | 45,406,946 | RGD:6480464 | CTD | |
| G | TOP1 | topoisomerase (DNA) I |
|
multiple interactions | ISO | 20 | 39,657,462 | 39,753,127 | RGD:6480464 | CTD | |
| G | TOR1AIP1 | torsin A interacting protein 1 |
|
multiple interactions | ISO | 1 | 179,851,177 | 179,889,212 | RGD:6480464 | CTD | |
| G | TOX | thymocyte selection-associated high mobility group box |
|
multiple interactions | ISO | 8 | 59,717,977 | 60,031,767 | RGD:6480464 | CTD | |
| G | TOX3 | TOX high mobility group box family member 3 |
|
multiple interactions | ISO | 16 | 52,471,918 | 52,581,714 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
affects methylation | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
affects expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
affects expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
affects expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53I11 | tumor protein p53 inducible protein 11 |
|
multiple interactions | ISO | 11 | 44,953,899 | 44,972,857 | RGD:6480464 | CTD | |
| G | TPCN2 | two pore segment channel 2 |
|
multiple interactions | ISO | 11 | 68,816,350 | 68,858,072 | RGD:6480464 | CTD | |
| G | TPD52 | tumor protein D52 |
|
multiple interactions | ISO | 8 | 80,947,103 | 81,083,836 | RGD:6480464 | CTD | |
| G | TPD52L1 | tumor protein D52-like 1 |
|
multiple interactions | ISO | 6 | 125,474,879 | 125,584,644 | RGD:6480464 | CTD | |
| G | TPM1 | tropomyosin 1 (alpha) |
|
multiple interactions | ISO | 15 | 63,334,838 | 63,364,114 | RGD:6480464 | CTD | |
| G | TPM4 | tropomyosin 4 |
|
multiple interactions | ISO | 19 | 16,178,317 | 16,213,813 | RGD:6480464 | CTD | |
| G | TPP2 | tripeptidyl peptidase II |
|
multiple interactions | ISO | 13 | 103,249,286 | 103,331,524 | RGD:6480464 | CTD | |
| G | TPRG1L | tumor protein p63 regulated 1-like |
|
multiple interactions | ISO | 1 | 3,541,556 | 3,546,695 | RGD:6480464 | CTD | |
| G | TPST1 | tyrosylprotein sulfotransferase 1 |
|
multiple interactions | ISO | 7 | 65,670,259 | 65,825,438 | RGD:6480464 | CTD | |
| G | TPT1 | tumor protein, translationally-controlled 1 |
|
multiple interactions | ISO | 13 | 45,911,304 | 45,915,297 | RGD:6480464 | CTD | |
| G | TPX2 | TPX2, microtubule-associated, homolog (Xenopus laevis) |
|
multiple interactions | ISO | 20 | 30,326,904 | 30,389,603 | RGD:6480464 | CTD | |
| G | TRA2B | transformer 2 beta homolog (Drosophila) |
|
multiple interactions | ISO | 3 | 185,632,356 | 185,655,924 | RGD:6480464 | CTD | |
| G | TRAF1 | TNF receptor-associated factor 1 |
|
affects expression | EXP | 9 | 123,664,671 | 123,691,451 | RGD:6480464 | CTD | |
| G | TRAF4 | TNF receptor-associated factor 4 |
|
affects expression | EXP | 17 | 27,071,023 | 27,077,976 | RGD:6480464 | CTD | |
| G | TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
affects expression | EXP | 11 | 36,505,317 | 36,531,863 | RGD:6480464 | CTD | |
| G | TRAIP | TRAF interacting protein |
|
affects expression | EXP | 3 | 49,866,028 | 49,893,992 | RGD:6480464 | CTD | |
| G | TRAIP | TRAF interacting protein |
|
multiple interactions | ISO | 3 | 49,866,028 | 49,893,992 | RGD:6480464 | CTD | |
| G | TRAK1 | trafficking protein, kinesin binding 1 |
|
multiple interactions | ISO | 3 | 42,132,746 | 42,267,382 | RGD:6480464 | CTD | |
| G | TRAM2 | translocation associated membrane protein 2 |
|
multiple interactions | ISO | 6 | 52,362,200 | 52,441,862 | RGD:6480464 | CTD | |
| G | TRAP1 | TNF receptor-associated protein 1 |
|
multiple interactions | ISO | 16 | 3,708,038 | 3,767,598 | RGD:6480464 | CTD | |
| G | TREH | trehalase (brush-border membrane glycoprotein) |
|
multiple interactions | ISO | 11 | 118,528,942 | 118,550,381 | RGD:6480464 | CTD | |
| G | TREM1 | triggering receptor expressed on myeloid cells 1 |
|
multiple interactions | ISO | 6 | 41,242,999 | 41,254,457 | RGD:6480464 | CTD | |
| G | TREM2 | triggering receptor expressed on myeloid cells 2 |
|
multiple interactions | ISO | 6 | 41,126,246 | 41,130,922 | RGD:6480464 | CTD | |
| G | TREML4 | triggering receptor expressed on myeloid cells-like 4 |
|
multiple interactions | ISO | 6 | 41,196,062 | 41,206,120 | RGD:6480464 | CTD | |
| G | TRERF1 | transcriptional regulating factor 1 |
|
multiple interactions | ISO | 6 | 42,192,669 | 42,419,783 | RGD:6480464 | CTD | |
| G | TRHDE | thyrotropin-releasing hormone degrading enzyme |
|
multiple interactions | ISO | 12 | 72,666,529 | 73,059,422 | RGD:6480464 | CTD | |
| G | TRIAP1 | TP53 regulated inhibitor of apoptosis 1 |
|
multiple interactions | ISO | 12 | 120,881,764 | 120,884,215 | RGD:6480464 | CTD | |
| G | TRIB1 | tribbles homolog 1 (Drosophila) |
|
multiple interactions | ISO | 8 | 126,442,563 | 126,450,645 | RGD:6480464 | CTD | |
| G | TRIM11 | tripartite motif containing 11 |
|
multiple interactions | ISO | 1 | 228,581,377 | 228,594,517 | RGD:6480464 | CTD | |
| G | TRIM13 | tripartite motif containing 13 |
|
multiple interactions | ISO | 13 | 50,571,143 | 50,592,603 | RGD:6480464 | CTD | |
| G | TRIM16 | tripartite motif containing 16 |
|
multiple interactions | ISO | 17 | 15,531,280 | 15,586,193 | RGD:6480464 | CTD | |
| G | TRIM24 | tripartite motif containing 24 |
|
multiple interactions | ISO | 7 | 138,145,079 | 138,270,333 | RGD:6480464 | CTD | |
| G | TRIM27 | tripartite motif containing 27 |
|
multiple interactions | ISO | 6 | 28,870,779 | 28,891,768 | RGD:6480464 | CTD | |
| G | TRIM29 | tripartite motif containing 29 |
|
multiple interactions | ISO | 11 | 119,981,994 | 120,008,863 | RGD:6480464 | CTD | |
| G | TRIM35 | tripartite motif containing 35 |
|
multiple interactions | ISO | 8 | 27,142,404 | 27,168,834 | RGD:6480464 | CTD | |
| G | TRIM36 | tripartite motif containing 36 |
|
multiple interactions | ISO | 5 | 114,460,459 | 114,516,243 | RGD:6480464 | CTD | |
| G | TRIM41 | tripartite motif containing 41 |
|
multiple interactions | ISO | 5 | 180,650,263 | 180,662,808 | RGD:6480464 | CTD | |
| G | TRIM45 | tripartite motif containing 45 |
|
multiple interactions | ISO | 1 | 117,653,677 | 117,664,411 | RGD:6480464 | CTD | |
| G | TRIM6 | tripartite motif containing 6 |
|
multiple interactions | ISO | 11 | 5,617,331 | 5,634,188 | RGD:6480464 | CTD | |
| G | TRIM6 | tripartite motif containing 6 |
|
multiple interactions | ISO | 11 | 5,617,331 | 5,634,188 | RGD:6480464 | CTD | |
| G | TRIM71 | tripartite motif containing 71, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 3 | 32,859,510 | 32,933,771 | RGD:6480464 | CTD | |
| G | TRIO | trio Rho guanine nucleotide exchange factor |
|
multiple interactions | ISO | 5 | 14,143,829 | 14,509,458 | RGD:6480464 | CTD | |
| G | TRIP12 | thyroid hormone receptor interactor 12 |
|
multiple interactions | ISO | 2 | 230,631,930 | 230,786,655 | RGD:6480464 | CTD | |
| G | TRMT1 | tRNA methyltransferase 1 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 19 | 13,215,714 | 13,227,563 | RGD:6480464 | CTD | |
| G | TRMT12 | tRNA methyltransferase 12 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 8 | 125,463,048 | 125,465,267 | RGD:6480464 | CTD | |
| G | TRMT2A | tRNA methyltransferase 2 homolog A (S. cerevisiae) |
|
multiple interactions | ISO | 22 | 20,099,389 | 20,104,818 | RGD:6480464 | CTD | |
| G | TRMT5 | tRNA methyltransferase 5 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 14 | 61,438,159 | 61,447,782 | RGD:6480464 | CTD | |
| G | TRO | trophinin |
|
multiple interactions | ISO | X | 54,946,996 | 54,957,864 | RGD:6480464 | CTD | |
| G | TROVE2 | TROVE domain family, member 2 |
|
multiple interactions | ISO | 1 | 193,028,552 | 193,060,907 | RGD:6480464 | CTD | |
| G | TRPC4AP | transient receptor potential cation channel, subfamily C, member 4 associated protein |
|
multiple interactions | ISO | 20 | 33,590,207 | 33,680,618 | RGD:6480464 | CTD | |
| G | TRPM4 | transient receptor potential cation channel, subfamily M, member 4 |
|
multiple interactions | ISO | 19 | 49,661,016 | 49,715,098 | RGD:6480464 | CTD | |
| G | TRPS1 | trichorhinophalangeal syndrome I |
|
multiple interactions | ISO | 8 | 116,420,724 | 116,681,228 | RGD:6480464 | CTD | |
| G | TRPV2 | transient receptor potential cation channel, subfamily V, member 2 |
|
multiple interactions | ISO | 17 | 16,318,856 | 16,340,317 | RGD:6480464 | CTD | |
| G | TRPV4 | transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions | ISO | 12 | 110,220,892 | 110,271,212 | RGD:6480464 | CTD | |
| G | TSC22D1 | TSC22 domain family, member 1 |
|
multiple interactions | ISO | 13 | 45,006,279 | 45,150,701 | RGD:6480464 | CTD | |
| G | TSGA10 | testis specific, 10 |
|
multiple interactions | ISO | 2 | 99,613,724 | 99,771,187 | RGD:6480464 | CTD | |
| G | TSHZ1 | teashirt zinc finger homeobox 1 |
|
multiple interactions | ISO | 18 | 72,922,710 | 73,001,905 | RGD:6480464 | CTD | |
| G | TSHZ3 | teashirt zinc finger homeobox 3 |
|
multiple interactions | ISO | 19 | 31,765,851 | 31,840,190 | RGD:6480464 | CTD | |
| G | TSPYL4 | TSPY-like 4 |
|
multiple interactions | ISO | 6 | 116,571,127 | 116,575,261 | RGD:6480464 | CTD | |
| G | TSSK6 | testis-specific serine kinase 6 |
|
multiple interactions | ISO | 19 | 19,625,028 | 19,626,469 | RGD:6480464 | CTD | |
| G | TSTA3 | tissue specific transplantation antigen P35B |
|
multiple interactions | ISO | 8 | 144,694,788 | 144,699,732 | RGD:6480464 | CTD | |
| G | TTC12 | tetratricopeptide repeat domain 12 |
|
multiple interactions | ISO | 11 | 113,185,251 | 113,237,114 | RGD:6480464 | CTD | |
| G | TTC21A | tetratricopeptide repeat domain 21A |
|
multiple interactions | ISO | 3 | 39,149,152 | 39,180,394 | RGD:6480464 | CTD | |
| G | TTC21A | tetratricopeptide repeat domain 21A |
|
multiple interactions | ISO | 3 | 39,149,152 | 39,180,394 | RGD:6480464 | CTD | |
| G | TTC21B | tetratricopeptide repeat domain 21B |
|
multiple interactions | ISO | 2 | 166,729,872 | 166,810,348 | RGD:6480464 | CTD | |
| G | TTC22 | tetratricopeptide repeat domain 22 |
|
multiple interactions | ISO | 1 | 55,246,752 | 55,266,941 | RGD:6480464 | CTD | |
| G | TTC26 | tetratricopeptide repeat domain 26 |
|
multiple interactions | ISO | 7 | 138,818,490 | 138,874,550 | RGD:6480464 | CTD | |
| G | TTC34 | tetratricopeptide repeat domain 34 |
|
multiple interactions | ISO | 1 | 2,572,807 | 2,706,230 | RGD:6480464 | CTD | |
| G | TTF2 | transcription termination factor, RNA polymerase II |
|
multiple interactions | ISO | 1 | 117,602,949 | 117,645,492 | RGD:6480464 | CTD | |
| G | TTK | TTK protein kinase |
|
multiple interactions | ISO | 6 | 80,714,322 | 80,752,244 | RGD:6480464 | CTD | |
| G | TTLL3 | tubulin tyrosine ligase-like family, member 3 |
|
multiple interactions | ISO | 3 | 9,851,644 | 9,878,040 | RGD:6480464 | CTD | |
| G | TUBA1A | tubulin, alpha 1a |
|
multiple interactions | EXP | 12 | 49,578,578 | 49,583,107 | RGD:6480464 | CTD | |
| G | TUBA3E | tubulin, alpha 3e |
|
multiple interactions | ISO | 2 | 130,949,318 | 130,956,034 | RGD:6480464 | CTD | |
| G | TUBA4A | tubulin, alpha 4a |
|
multiple interactions | ISO | 2 | 220,115,001 | 220,118,638 | RGD:6480464 | CTD | |
| G | TUBA8 | tubulin, alpha 8 |
|
multiple interactions | ISO | 22 | 18,593,453 | 18,614,498 | RGD:6480464 | CTD | |
| G | TUBB2A | tubulin, beta 2A class IIa |
|
multiple interactions | ISO | 6 | 3,153,900 | 3,157,783 | RGD:6480464 | CTD | |
| G | TUBB6 | tubulin, beta 6 class V |
|
multiple interactions | ISO | 18 | 12,308,257 | 12,326,568 | RGD:6480464 | CTD | |
| G | TUBG2 | tubulin, gamma 2 |
|
multiple interactions | ISO | 17 | 40,811,266 | 40,819,024 | RGD:6480464 | CTD | |
| G | TUBGCP3 | tubulin, gamma complex associated protein 3 |
|
multiple interactions | ISO | 13 | 113,139,328 | 113,242,481 | RGD:6480464 | CTD | |
| G | TUBGCP5 | tubulin, gamma complex associated protein 5 |
|
multiple interactions | ISO | 15 | 22,833,395 | 22,873,891 | RGD:6480464 | CTD | |
| G | TUG1 | taurine upregulated 1 (non-protein coding) |
|
increases expression | EXP | 22 | 31,365,634 | 31,375,381 | RGD:6480464 | CTD | |
| G | TULP1 | tubby like protein 1 |
|
multiple interactions | ISO | 6 | 35,465,651 | 35,480,647 | RGD:6480464 | CTD | |
| G | TUSC3 | tumor suppressor candidate 3 |
|
multiple interactions | ISO | 8 | 15,397,596 | 15,624,158 | RGD:6480464 | CTD | |
| G | TWF1 | twinfilin actin-binding protein 1 |
|
multiple interactions | ISO | 12 | 44,187,526 | 44,200,178 | RGD:6480464 | CTD | |
| G | TWF2 | twinfilin actin-binding protein 2 |
|
multiple interactions | ISO | 3 | 52,262,626 | 52,273,183 | RGD:6480464 | CTD | |
| G | TWIST1 | twist basic helix-loop-helix transcription factor 1 |
|
multiple interactions | ISO | 7 | 19,155,091 | 19,157,295 | RGD:6480464 | CTD | |
| G | TWIST2 | twist basic helix-loop-helix transcription factor 2 |
|
multiple interactions | ISO | 2 | 239,756,673 | 239,795,893 | RGD:6480464 | CTD | |
| G | TXNDC9 | thioredoxin domain containing 9 |
|
multiple interactions | ISO | 2 | 99,935,487 | 99,952,860 | RGD:6480464 | CTD | |
| G | TXNIP | thioredoxin interacting protein |
|
increases expression | EXP | 1 | 145,438,462 | 145,442,635 | RGD:6480464 | CTD | |
| G | TXNL1 | thioredoxin-like 1 |
|
multiple interactions | ISO | 18 | 54,270,053 | 54,305,920 | RGD:6480464 | CTD | |
| G | TXNRD3 | thioredoxin reductase 3 |
|
multiple interactions | ISO | 3 | 126,325,895 | 126,373,967 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
decreases activity | EXP | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
affects expression | EXP | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
increases expression | ISO | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
affects expression | EXP | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | U2AF2 | U2 small nuclear RNA auxiliary factor 2 |
|
multiple interactions | ISO | 19 | 56,165,416 | 56,186,082 | RGD:6480464 | CTD | |
| G | UAP1L1 | UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
|
multiple interactions | ISO | 9 | 139,971,953 | 139,978,990 | RGD:6480464 | CTD | |
| G | UBE2A | ubiquitin-conjugating enzyme E2A |
|
multiple interactions | ISO | X | 118,708,499 | 118,718,381 | RGD:6480464 | CTD | |
| G | UBE2B | ubiquitin-conjugating enzyme E2B |
|
multiple interactions | ISO | 5 | 133,706,870 | 133,727,799 | RGD:6480464 | CTD | |
| G | UBE2C | ubiquitin-conjugating enzyme E2C |
|
multiple interactions | ISO | 20 | 44,441,255 | 44,445,596 | RGD:6480464 | CTD | |
| G | UBE2H | ubiquitin-conjugating enzyme E2H |
|
multiple interactions | ISO | 7 | 129,470,572 | 129,592,800 | RGD:6480464 | CTD | |
| G | UBE2Q1 | ubiquitin-conjugating enzyme E2Q family member 1 |
|
multiple interactions | ISO | 1 | 154,521,051 | 154,531,120 | RGD:6480464 | CTD | |
| G | UBE2S | ubiquitin-conjugating enzyme E2S |
|
multiple interactions | ISO | 19 | 55,912,650 | 55,919,325 | RGD:6480464 | CTD | |
| G | UBOX5 | U-box domain containing 5 |
|
multiple interactions | ISO | 20 | 3,088,219 | 3,140,556 | RGD:6480464 | CTD | |
| G | UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
multiple interactions | ISO | 4 | 41,258,898 | 41,270,446 | RGD:6480464 | CTD | |
| G | UGGT2 | UDP-glucose glycoprotein glucosyltransferase 2 |
|
multiple interactions | ISO | 13 | 96,453,834 | 96,705,736 | RGD:6480464 | CTD | |
| G | UHRF1 | ubiquitin-like with PHD and ring finger domains 1 |
|
multiple interactions | ISO | 19 | 4,909,510 | 4,962,165 | RGD:6480464 | CTD | |
| G | UHRF1BP1 | UHRF1 binding protein 1 |
|
multiple interactions | ISO | 6 | 34,759,794 | 34,845,291 | RGD:6480464 | CTD | |
| G | UNC13A | unc-13 homolog A (C. elegans) |
|
multiple interactions | ISO | 19 | 17,712,137 | 17,799,008 | RGD:6480464 | CTD | |
| G | UNC13B | unc-13 homolog B (C. elegans) |
|
multiple interactions | ISO | 9 | 35,161,989 | 35,405,332 | RGD:6480464 | CTD | |
| G | UNC5B | unc-5 homolog B (C. elegans) |
|
multiple interactions | ISO | 10 | 72,972,292 | 73,062,635 | RGD:6480464 | CTD | |
| G | UNCX | UNC homeobox |
|
multiple interactions | ISO | 7 | 1,272,654 | 1,276,613 | RGD:6480464 | CTD | |
| G | UPF1 | UPF1 regulator of nonsense transcripts homolog (yeast) |
|
multiple interactions | ISO | 19 | 18,942,744 | 18,979,039 | RGD:6480464 | CTD | |
| G | UQCRFS1 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
|
multiple interactions | ISO | 19 | 29,698,167 | 29,704,136 | RGD:6480464 | CTD | |
| G | USF2 | upstream transcription factor 2, c-fos interacting |
|
multiple interactions | ISO | 19 | 35,759,896 | 35,770,718 | RGD:6480464 | CTD | |
| G | USP10 | ubiquitin specific peptidase 10 |
|
multiple interactions | ISO | 16 | 84,733,555 | 84,813,528 | RGD:6480464 | CTD | |
| G | USP15 | ubiquitin specific peptidase 15 |
|
multiple interactions | ISO | 12 | 62,654,121 | 62,803,501 | RGD:6480464 | CTD | |
| G | USP2 | ubiquitin specific peptidase 2 |
|
multiple interactions | ISO | 11 | 119,225,925 | 119,252,436 | RGD:6480464 | CTD | |
| G | USP21 | ubiquitin specific peptidase 21 |
|
multiple interactions | ISO | 1 | 161,129,254 | 161,135,516 | RGD:6480464 | CTD | |
| G | USP3 | ubiquitin specific peptidase 3 |
|
multiple interactions | ISO | 15 | 63,796,710 | 63,886,839 | RGD:6480464 | CTD | |
| G | USP38 | ubiquitin specific peptidase 38 |
|
multiple interactions | ISO | 4 | 144,106,070 | 144,143,141 | RGD:6480464 | CTD | |
| G | USP43 | ubiquitin specific peptidase 43 |
|
multiple interactions | ISO | 17 | 9,548,854 | 9,633,004 | RGD:6480464 | CTD | |
| G | USP45 | ubiquitin specific peptidase 45 |
|
multiple interactions | ISO | 6 | 99,880,182 | 99,963,252 | RGD:6480464 | CTD | |
| G | USP53 | ubiquitin specific peptidase 53 |
|
affects expression | EXP | 4 | 120,133,782 | 120,216,673 | RGD:6480464 | CTD | |
| G | USP53 | ubiquitin specific peptidase 53 |
|
multiple interactions | ISO | 4 | 120,133,782 | 120,216,673 | RGD:6480464 | CTD | |
| G | USP8 | ubiquitin specific peptidase 8 |
|
multiple interactions | ISO | 15 | 50,716,579 | 50,793,277 | RGD:6480464 | CTD | |
| G | USPL1 | ubiquitin specific peptidase like 1 |
|
multiple interactions | ISO | 13 | 31,191,830 | 31,233,686 | RGD:6480464 | CTD | |
| G | UTF1 | undifferentiated embryonic cell transcription factor 1 |
|
multiple interactions | ISO | 10 | 135,043,778 | 135,045,062 | RGD:6480464 | CTD | |
| G | UTP15 | UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) |
|
multiple interactions | ISO | 5 | 72,861,598 | 72,877,794 | RGD:6480464 | CTD | |
| G | UTS2B | urotensin 2B |
|
multiple interactions | ISO | 3 | 190,984,944 | 191,048,325 | RGD:6480464 | CTD | |
| G | VAMP1 | vesicle-associated membrane protein 1 (synaptobrevin 1) |
|
multiple interactions | ISO | 12 | 6,571,403 | 6,579,843 | RGD:6480464 | CTD | |
| G | VASP | vasodilator-stimulated phosphoprotein |
|
multiple interactions | ISO | 19 | 46,010,688 | 46,030,241 | RGD:6480464 | CTD | |
| G | VAT1 | vesicle amine transport protein 1 homolog (T. californica) |
|
multiple interactions | ISO | 17 | 41,166,622 | 41,174,459 | RGD:6480464 | CTD | |
| G | VAV2 | vav 2 guanine nucleotide exchange factor |
|
multiple interactions | ISO | 9 | 136,627,016 | 136,857,446 | RGD:6480464 | CTD | |
| G | VAX1 | ventral anterior homeobox 1 |
|
multiple interactions | ISO | 10 | 118,888,032 | 118,897,812 | RGD:6480464 | CTD | |
| G | VAX2 | ventral anterior homeobox 2 |
|
multiple interactions | ISO | 2 | 71,127,720 | 71,160,576 | RGD:6480464 | CTD | |
| G | VCAM1 | vascular cell adhesion molecule 1 |
|
decreases expression | ISO | 1 | 101,185,196 | 101,204,601 | RGD:6480464 | CTD | |
| G | VCAM1 | vascular cell adhesion molecule 1 |
|
multiple interactions | ISO | 1 | 101,185,196 | 101,204,601 | RGD:6480464 | CTD | |
| G | VDAC1 | voltage-dependent anion channel 1 |
|
multiple interactions | ISO | 5 | 133,307,566 | 133,340,824 | RGD:6480464 | CTD | |
| G | VEGFA | vascular endothelial growth factor A |
|
decreases expression | ISO | 6 | 43,737,946 | 43,754,224 | RGD:6480464 | CTD | |
| G | VEGFA | vascular endothelial growth factor A |
|
affects expression | EXP | 6 | 43,737,946 | 43,754,224 | RGD:6480464 | CTD | |
| G | VEGFA | vascular endothelial growth factor A |
|
multiple interactions | ISO | 6 | 43,737,946 | 43,754,224 | RGD:6480464 | CTD | |
| G | VEZF1 | vascular endothelial zinc finger 1 |
|
multiple interactions | ISO | 17 | 56,048,910 | 56,065,615 | RGD:6480464 | CTD | |
| G | VGF | VGF nerve growth factor inducible |
|
multiple interactions | ISO | 7 | 100,805,790 | 100,808,852 | RGD:6480464 | CTD | |
| G | VGLL3 | vestigial like 3 (Drosophila) |
|
affects expression | EXP | 3 | 86,987,123 | 87,040,257 | RGD:6480464 | CTD | |
| G | VHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
increases expression | ISO | 3 | 10,183,319 | 10,195,354 | RGD:6480464 | CTD | |
| G | WDR45B | WD repeat domain 45B |
|
multiple interactions | ISO | 17 | 80,572,438 | 80,606,411 | RGD:6480464 | CTD | |
| G | WDR67 | WD repeat domain 67 |
|
multiple interactions | ISO | 8 | 124,084,920 | 124,164,393 | RGD:6480464 | CTD | |
| G | WISP1 | WNT1 inducible signaling pathway protein 1 |
|
affects expression | EXP | 8 | 134,203,282 | 134,243,933 | RGD:6480464 | CTD | |
| G | WNT5A | wingless-type MMTV integration site family, member 5A |
|
affects expression | EXP | 3 | 55,499,743 | 55,521,670 | RGD:6480464 | CTD | |
| G | ZBTB14 | zinc finger and BTB domain containing 14 |
|
multiple interactions | ISO | 18 | 5,289,018 | 5,297,052 | RGD:6480464 | CTD | |
| G | ZHX2 | zinc fingers and homeoboxes 2 |
|
multiple interactions | ISO | 8 | 123,793,901 | 123,986,755 | RGD:6480464 | CTD | |
| G | ZIC3 | Zic family member 3 |
|
multiple interactions | ISO | X | 136,648,346 | 136,654,259 | RGD:6480464 | CTD | |
| G | ZIK1 | zinc finger protein interacting with K protein 1 |
|
multiple interactions | ISO | 19 | 58,095,628 | 58,103,758 | RGD:6480464 | CTD | |
| G | ZMIZ1 | zinc finger, MIZ-type containing 1 |
|
multiple interactions | ISO | 10 | 80,828,792 | 81,076,285 | RGD:6480464 | CTD | |
| G | ZMYM6 | zinc finger, MYM-type 6 |
|
multiple interactions | ISO | 1 | 35,451,766 | 35,497,569 | RGD:6480464 | CTD | |
| G | ZNF219 | zinc finger protein 219 |
|
affects expression | EXP | 14 | 21,558,205 | 21,572,863 | RGD:6480464 | CTD | |
| G | ZNRF1 | zinc and ring finger 1, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 16 | 75,032,915 | 75,144,892 | RGD:6480464 | CTD | |
| G | ZPBP | zona pellucida binding protein |
|
multiple interactions | ISO | 7 | 49,977,023 | 50,132,860 | RGD:6480464 | CTD | |
| G | ZSCAN12 | zinc finger and SCAN domain containing 12 |
|
multiple interactions | ISO | 6 | 28,346,598 | 28,367,544 | RGD:6480464 | CTD | |
| G | ZSWIM4 | zinc finger, SWIM-type containing 4 |
|
multiple interactions | ISO | 19 | 13,906,274 | 13,943,044 | RGD:6480464 | CTD | |
| G | ZSWIM5 | zinc finger, SWIM-type containing 5 |
|
multiple interactions | ISO | 1 | 45,482,074 | 45,672,250 | RGD:6480464 | CTD | |
Term paths to the root
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term